{"content":"<li class=\"n-box-item date-title\" data-end=\"1569297599\" data-start=\"1569211200\" data-txt=\"Monday, December 23, 2019\">Monday, September 23, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3501344\" data-ts=\"1569279192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMDI\" target=\"_blank\">TMDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501344-titan-medicalminus-1_9-after-filing-to-offer-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Medical -1.9% after filing to offer units</a></h4><ul>   <li>Titan Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/TMDI' title='Titan Medical Inc.'>TMDI</a>) is <font color=\"red\">1.9%</font> lower postmarket after <a href=\"https://seekingalpha.com/filing/4642029\" target=\"_blank\">filing to offer</a> up to $22M in units.</li>    <li>The units consist of a common share and a warrant to purchase a common share.</li>    <li><a href='https://seekingalpha.com/symbol/TMDI' title='Titan Medical Inc.'>TMDI</a> is <font color=\"red\">down 30.9%</font> over the past six months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501344\" data-linked=\"Titan Medical -1.9% after filing to offer units\" data-tweet=\"$TMDI - Titan Medical -1.9% after filing to offer units https://seekingalpha.com/news/3501344-titan-medicalminus-1_9-after-filing-to-offer-units?source=tweet\" data-url=\"https://seekingalpha.com/news/3501344-titan-medicalminus-1_9-after-filing-to-offer-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501339\" data-ts=\"1569277525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTER\" target=\"_blank\">WTER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501339-alkaline-water-holders-file-to-offer-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alkaline Water holders file to offer shares</a></h4><ul>   <li>Alkaline Water (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) shareholders have filed to <a href=\"https://seekingalpha.com/filing/4641868\" target=\"_blank\">offer up to 2.2M shares</a> of the company's common stock.</li>    <li>Shares are <font color=\"green\">up 1.7%</font> after hours.</li>    <li>The company won't receive any proceeds from any holders' sale of shares.</li>    <li>Selling stockholders include Orpal Trading (registering its entire stake of 1.05M shares); Paisley Capital Holdings (also registering an entire stake of 1.05M shares); and Viola May Suffron, registering 100K of holdings that total 1.385M shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501339\" data-linked=\"Alkaline Water holders file to offer shares\" data-tweet=\"$WTER - Alkaline Water holders file to offer shares https://seekingalpha.com/news/3501339-alkaline-water-holders-file-to-offer-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3501339-alkaline-water-holders-file-to-offer-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501334\" data-ts=\"1569274408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDP\" target=\"_blank\">FDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501334-fresh-del-monte-jagged-peak-joining-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fresh Del Monte, Jagged Peak joining SmallCap 600</a></h4><ul>   <li>Fresh Del Monte Produce (NYSE:<a href='https://seekingalpha.com/symbol/FDP' title='Fresh Del Monte Produce Inc.'>FDP</a>) is <font color=\"green\">up 5.5%</font> on a <a href=\"https://us.spindices.com/documents/indexnews/announcements/20190923-1001159/1001159_6delmontejagged.pdf?force_download=true\" target=\"_blank\">move into the S&amp;P SmallCap 600</a>.</li>    <li>Fresh Del Monte will replace Cray (NASDAQ:<a href='https://seekingalpha.com/symbol/CRAY' title='Cray Inc.'>CRAY</a>), which is set to be acquired by Hewlett Packard Enterprise.</li>    <li>Jagged Peak Energy (NYSE:<a href='https://seekingalpha.com/symbol/JAG' title='Jagged Peak Energy Inc.'>JAG</a>), meanwhile, will replace NorthStar Realty Europe (NYSE:<a href='https://seekingalpha.com/symbol/NRE' title='Northstar Realty Europe Corp.'>NRE</a>), which is about to be acquired by AXA Investment Managers, in the SmallCap 600.</li>    <li>The new additions are effective prior to the open next Monday, Sept. 30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501334\" data-linked=\"Fresh Del Monte, Jagged Peak joining SmallCap 600\" data-tweet=\"$FDP $JAG $FDP - Fresh Del Monte, Jagged Peak joining SmallCap 600 https://seekingalpha.com/news/3501334-fresh-del-monte-jagged-peak-joining-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3501334-fresh-del-monte-jagged-peak-joining-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501332\" data-ts=\"1569274150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501332-azpn-iphi-ghc-and-hta-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AZPN, IPHI, GHC and HTA among after hour movers</a></h4><div><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/AZPN' title='Aspen Technology, Inc.'>AZPN</a> <font color=\"green\">+9.38%</font>. <a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a> <font color=\"green\">+4.99%</font>. <a href='https://seekingalpha.com/symbol/AIR' title='AAR Corp.'>AIR</a> <font color=\"green\">+4.98%</font>. <a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a> <font color=\"green\">+4.45%</font>. <a href='https://seekingalpha.com/symbol/RDN' title='Radian Group Inc.'>RDN</a> <font color=\"green\">+4.34%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/GHC' title='Graham Holdings Company'>GHC</a> <font color=\"red\">-4.18%</font>. <a href='https://seekingalpha.com/symbol/IGD' title='Voya Global Equity Dividend and Premium Opportunity Fund'>IGD</a> <font color=\"red\">-3.77%</font>. <a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a> <font color=\"red\">-3.48%</font>. <a href='https://seekingalpha.com/symbol/BRKMY' title='Braskem S.A.'>OTCPK:BRKMY</a> <font color=\"red\">-3.45%</font>. <a href='https://seekingalpha.com/symbol/HTA' title='Healthcare Trust of America, Inc.'>HTA</a> <font color=\"red\">-2.84%</font>.</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3501332\" data-linked=\"AZPN, IPHI, GHC and HTA among after hour movers\" data-tweet=\"$AZPN $IPHI $AIR - AZPN, IPHI, GHC and HTA among after hour movers https://seekingalpha.com/news/3501332-azpn-iphi-ghc-and-hta-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501332-azpn-iphi-ghc-and-hta-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501327\" data-ts=\"1569272511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDD\" target=\"_blank\">PDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501327-pinduoduominus-1_5-on-convertible-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinduoduo -1.5% on convertible note offering</a></h4><ul><li>Pinduoduo (NASDAQ:<a href='https://seekingalpha.com/symbol/PDD' title='Pinduoduo Inc.'>PDD</a>) <font color=\"red\">-1.5%</font> <a href=\"https://seekingalpha.com/pr/17640850-pinduoduo-announces-proposed-offering-us-875-million-convertible-senior-notes\" target=\"_blank\">proposes an offering</a> of $875M in convertible senior notes due 2024.</li><li>The company will grant initial purchasers a 13-day option to buy up to an additional $125M.</li><li>PDD will use the proceeds to expand business operations, for R&amp;D, and to invest in its tech infrastructure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501327\" data-linked=\"Pinduoduo -1.5% on convertible note offering\" data-tweet=\"$PDD - Pinduoduo -1.5% on convertible note offering https://seekingalpha.com/news/3501327-pinduoduominus-1_5-on-convertible-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3501327-pinduoduominus-1_5-on-convertible-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501314\" data-ts=\"1569270789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VER\" target=\"_blank\">VER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501314-vereit-launches-stock-offering-shares-fall-2_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vereit launches stock offering; shares fall 2.7%</a></h4><ul><li>Vereit (NYSE:<a href='https://seekingalpha.com/symbol/VER' title='VEREIT, Inc.'>VER</a>) <font color=\"red\">sinks 2.7%</font> in after-hours trading after starting a <a href=\"https://seekingalpha.com/pr/17640802-vereit-inc-announces-public-offering-common-stock\" target=\"_blank\">public offering </a>of 71M shares of common stock.</li><li>Expects to grant greenshoe option for up to an additional 10.65M shares.</li><li>Plans to use proceeds to pay amounts owed in connection with the settlement of certain litigation and for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501314\" data-linked=\"Vereit launches stock offering; shares fall 2.7%\" data-tweet=\"$VER - Vereit launches stock offering; shares fall 2.7% https://seekingalpha.com/news/3501314-vereit-launches-stock-offering-shares-fall-2_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3501314-vereit-launches-stock-offering-shares-fall-2_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501308\" data-ts=\"1569270541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLMR\" target=\"_blank\">PLMR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501308-palomar-holdingsminus-2_1-after-secondary-stock-offering-launched\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palomar Holdings -2.1% after secondary stock offering launched</a></h4><ul><li>Palomar Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PLMR' title='Palomar Holdings, Inc.'>PLMR</a>)<font color=\"red\"> falls 2.1%</font> in after-hours trading after announcing that affiliates of Genstar Capital and certain directors and officers of Palomar <a href=\"https://seekingalpha.com/pr/17640763-palomar-holdings-inc-launches-secondary-public-offering\" target=\"_blank\">are offerin</a>g 5M shares of common stock in an underwritten public offering.</li><li>Additionally, the Genstar affiliates plan to grant a greenshoe option for an additional 750,000 shares of common stock.</li><li>Genstar<a href=\"https://seekingalpha.com/filing/4641940#A2239559ZS-1_HTM_EA13901_PRINCIPAL_AND_SELLING_STOCKHOLDERS\" target=\"_blank\"> plans to offer</a> 4.9M of the shares to be sold in the offering.</li><li>Among Palomar officers and directors, Mac Armstrong will offer 40,000 shares, Heath Fisher will offer 35,000 shares, and Jon Christianson will offer 6,500 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501308\" data-linked=\"Palomar Holdings -2.1% after secondary stock offering launched\" data-tweet=\"$PLMR - Palomar Holdings -2.1% after secondary stock offering launched https://seekingalpha.com/news/3501308-palomar-holdingsminus-2_1-after-secondary-stock-offering-launched?source=tweet\" data-url=\"https://seekingalpha.com/news/3501308-palomar-holdingsminus-2_1-after-secondary-stock-offering-launched\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501293\" data-ts=\"1569268703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AT\" target=\"_blank\">AT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501293-atlantic-power-reports-fire-cadillac-biomass-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlantic Power reports fire at Cadillac biomass plant</a></h4><ul><li>Atlantic Power (<a href='https://seekingalpha.com/symbol/AT' title='Atlantic Power Corporation'>AT</a> <font color='red'>-2.6%</font>) says its Cadillac biomass plant in Michigan is <a href=\"https://seekingalpha.com/pr/17640647-atlantic-power-corporation-comments-fire-cadillac-biomass-plant\" target=\"_blank\">currently offline</a> following a weekend fire at the plant.</li><li>AT says it does not yet know the cause of the fire, and it is assessing the extent of the damage to its facility; an update will be provided when it issues Q3 results.</li><li>Cadillac contributed $3.4M to the company's project adjusted EBITDA in the  first six months of 2019, or 3% of total project adjusted EBITDA.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501293\" data-linked=\"Atlantic Power reports fire at Cadillac biomass plant\" data-tweet=\"$AT - Atlantic Power reports fire at Cadillac biomass plant https://seekingalpha.com/news/3501293-atlantic-power-reports-fire-cadillac-biomass-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3501293-atlantic-power-reports-fire-cadillac-biomass-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501289\" data-ts=\"1569268196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLD\" target=\"_blank\">GLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501289-gold-silver-enjoy-safe-haven-action-palladium-pops-to-new-record-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold, silver enjoy safe-haven action; palladium pops to new record high</a></h4><ul><li><a href=\"https://www.cnbc.com/2019/09/23/gold-markets-us-china-trade-palladium-in-focus.html\" target=\"_blank\">Gold futures climbed</a> to their highest in more than two weeks, with December Comex gold (<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> <font color='green'>+0.5%</font>) settling <font color=\"green\">+1.1%</font> to $1,431.50/oz., and silver <font color=\"green\">+4.2%</font> to $18.61/oz, as weak European economic  data rekindled global recession worries.</li><li>\"Weak German PMI numbers gave a little bit of a shock to the stock market and led investors into safety like gold and silver,\" said Phillip Streible, senior commodities strategist at RJO Futures.</li><li>Meanwhile, palladium soared to a new record high of $1,664.50/oz., capping a nearly 8% surge so far this month.</li><li>\"People are starting to realize that auto sales and production outside  of China is actually not so bad and so demand from the industrial sector  is stronger that what people thought,\" says CPM Group managing partner Jeffrey Christian.</li><li>Precious metals shares are mostly higher, including <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color=\"green\">+10%</font>, <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color=\"green\">+5.3%</font>, <a href='https://seekingalpha.com/symbol/PAAS' title='Pan American Silver Corp.'>PAAS</a> <font color=\"green\">+5.3%</font>, <a href='https://seekingalpha.com/symbol/KL' title='Kirkland Lake Gold Ltd.'>KL</a> <font color=\"green\">+5%</font>, <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color=\"green\">+4.3%</font>, <a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp.'>WPM</a> <font color=\"green\">+2.4%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color=\"green\">+1.6%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/SIVR' title='Aberd Std Silvr Shs'>SIVR</a>, <a href='https://seekingalpha.com/symbol/PALL' title='ETFS Physical Palladium Shares ETF'>PALL</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares Trust II - ProShares UltraShort Silver'>ZSL</a>, <a href='https://seekingalpha.com/symbol/SLVO' title='Credit Suisse Silver Shares Covered Call ETN'>SLVO</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust'>BAR</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares, Inc. - iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Trust - SPDR Gold MiniShares Trust'>GLDM</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust'>OUNZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3501289\" data-linked=\"Gold, silver enjoy safe-haven action; palladium pops to new record high\" data-tweet=\"$GLD $EXK $IAG - Gold, silver enjoy safe-haven action; palladium pops to new record high https://seekingalpha.com/news/3501289-gold-silver-enjoy-safe-haven-action-palladium-pops-to-new-record-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3501289-gold-silver-enjoy-safe-haven-action-palladium-pops-to-new-record-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501285\" data-ts=\"1569266871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501285-catalyst-pharma-down-16-on-higher-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma down 16% on higher volume</a></h4><ul><li>Catalyst Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color=\"red\">-15.6%</font>) slumps on more than a 4x surge in volume on no apparent news. In a statement, the company says it is \"not aware\" of any information that would account for the bearish action.</li><li>Two weeks ago, it backed away from an 8M-share stock offering due to adverse market conditions.</li><li>H1 revenue was $41.3M, all from Firdapse, launched in January.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501285\" data-linked=\"Catalyst Pharma down 16% on higher volume\" data-tweet=\"$CPRX - Catalyst Pharma down 16% on higher volume https://seekingalpha.com/news/3501285-catalyst-pharma-down-16-on-higher-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3501285-catalyst-pharma-down-16-on-higher-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501284\" data-ts=\"1569266612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXP\" target=\"_blank\">AXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501284-american-expressplus-1_3-after-boosting-dividend-announcing-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Express +1.3% after boosting dividend, announcing buyback</a></h4><ul><li>American Express (NYSE:<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a>)<font color=\"green\"> advances 1.3% </font>after <a href=\"https://seekingalpha.com/pr/17640707-american-express-board-authorizes-repurchase-120-million-shares-announces-10-percent-dividend\" target=\"_blank\">boosting its quarterly dividend</a> and approving a 120M-share buyback program.</li><li>AXP's board approved a 4-cent per share increase, or 10%, to 43 cents per share from its prior dividend.</li><li>Announces a program to buy up to 120M of common shares, replacing the prior repurchase authorization for up to 150M shares that was adopted in 2016.</li><li>At its recent price of $118.24 per share, the repurchase authorization represents ~$14.2B if it were exercised in full.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501284\" data-linked=\"American Express +1.3% after boosting dividend, announcing buyback\" data-tweet=\"$AXP - American Express +1.3% after boosting dividend, announcing buyback https://seekingalpha.com/news/3501284-american-expressplus-1_3-after-boosting-dividend-announcing-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3501284-american-expressplus-1_3-after-boosting-dividend-announcing-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501277\" data-ts=\"1569265301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501277-microcaps-mostly-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among tech movers</a></h4><ul><li><strong>Gainers:</strong>Helios and Matheson Analytics (<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics Inc.'>OTCPK:HMNY</a>) <font color=\"green\">+60%. </font>Interlink Electronics (<a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics, Inc.'>OTCPK:LINK</a>) <font color=\"green\">+22%</font>. Verb Technology Company (NASDAQ:<a href='https://seekingalpha.com/symbol/VERB' title='Verb Technology Company, Inc.'>VERB</a>) <font color=\"green\">+14%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings, Inc.'>AWSM</a>) <font color=\"green\">+12%</font>. VirTra (NASDAQ:<a href='https://seekingalpha.com/symbol/VTSI' title='VirTra, Inc.'>VTSI</a>) <font color=\"green\">+12%</font>.</li><li><strong>Losers: </strong>Pareteum Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"red\">-14%</font>. USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) <font color=\"red\">-11%</font>. Uxin Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"red\">-11%</font>. SCWorx (NASDAQ:<a href='https://seekingalpha.com/symbol/WORX' title='SCWorx Corp.'>WORX</a>) <font color=\"red\">-10%</font>. Ideanomics (NASDAQ:<a href='https://seekingalpha.com/symbol/IDEX' title='Ideanomics, Inc.'>IDEX</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501277\" data-linked=\"Microcaps mostly among tech movers\" data-tweet=\"$HMNY $LINK $VERB - Microcaps mostly among tech movers https://seekingalpha.com/news/3501277-microcaps-mostly-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501277-microcaps-mostly-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501262\" data-ts=\"1569262339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUN\" target=\"_blank\">IMUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501262-new-chief-immune-therapeutics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New chief at Immune Therapeutics</a></h4><ul><li>Immune Therapeutics (<a href='https://seekingalpha.com/symbol/IMUN' title='Immune Therapeutics, Inc.'>OTCPK:IMUN</a> <font color=\"green\">+4.3%</font>) <a href=\"https://seekingalpha.com/pr/17640302-immune-therapeutics-today-announces-appointment-michael-k-handley-new-chief-executive-officer\" target=\"_blank\">appoints </a>Michael Handley as CEO succeeding Noreen Griffin who resigned. He joins the firm from Aletheia Therapeutics where he was also CEO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501262\" data-linked=\"New chief at Immune Therapeutics\" data-tweet=\"$IMUN - New chief at Immune Therapeutics https://seekingalpha.com/news/3501262-new-chief-immune-therapeutics?source=tweet\" data-url=\"https://seekingalpha.com/news/3501262-new-chief-immune-therapeutics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501261\" data-ts=\"1569262222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPHI\" target=\"_blank\">IPHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501261-inphi-bull-says-buy-on-pullback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inphi bull says buy on pullback</a></h4><ul><li>Stifel defends Inphi (NYSE:<a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a>) after <a href=\"https://seekingalpha.com/news/3501256-inphi-bear-cautions-amazon-cuts-iphi-minus-3-percent\" target=\"_blank\">Northland's concerns</a> about a slower 400G PAM4 ramp.</li><li>Analyst Tore Svanberg says IPHI remains on track with 400G trial revenue from Amazon likely in H2 with \"significant\" growth next year.</li><li>The firm maintains a Buy rating and $70 target and recommends buying on the weakness. Inphi has an Outperform average <a href=\"https://seekingalpha.com/symbol/IPHI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Inphi shares are <font color=\"red\">down 2.9%</font> to $61.66.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501261\" data-linked=\"Inphi bull says buy on pullback\" data-tweet=\"$IPHI - Inphi bull says buy on pullback https://seekingalpha.com/news/3501261-inphi-bull-says-buy-on-pullback?source=tweet\" data-url=\"https://seekingalpha.com/news/3501261-inphi-bull-says-buy-on-pullback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501260\" data-ts=\"1569262039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTV\" target=\"_blank\">PSTV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501260-plus-therapeutics-prices-equity-offering-shares-down-49\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plus Therapeutics prices equity offering; shares down 49%</a></h4><ul><li>Plus Therapeutics (<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a> <font color=\"red\">-48.8%</font>) <a href=\"https://seekingalpha.com/pr/17640568-plus-therapeutics-inc-announces-pricing-15-million-underwritten-public-offering\" target=\"_blank\">prices </a>its public offering of 3M Units at $5.00 per Unit, each consisting of one common share and one five-year Series U warrant to purchase one common share at $5.00.</li><li>Underwriters over-allotment is an additional 450K common shares and/or Series U warrants to purchase up to 450K shares.</li><li>Gross proceeds should be ~$15M. Closing date is September 25.</li><li>Friday's close was $8.02.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501260\" data-linked=\"Plus Therapeutics prices equity offering; shares down 49%\" data-tweet=\"$PSTV - Plus Therapeutics prices equity offering; shares down 49% https://seekingalpha.com/news/3501260-plus-therapeutics-prices-equity-offering-shares-down-49?source=tweet\" data-url=\"https://seekingalpha.com/news/3501260-plus-therapeutics-prices-equity-offering-shares-down-49\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501258\" data-ts=\"1569261607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501258-contango-oil-gas-and-mcdermott-among-energy-materials-gainers-independence-contract-drilling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Contango Oil &amp; Gas and McDermott among Energy/Materials gainers; Independence Contract Drilling and Osisko Gold Royalties among losers</a></h4><ul><li><b>Gainers: </b>Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"green\">+14%</font>. McDermott (NYSE:<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a>) <font color=\"green\">+13%</font>. DRDGOLD (NYSE:<a href='https://seekingalpha.com/symbol/DRD' title='DRDGOLD Limited'>DRD</a>) <font color=\"green\">+10%</font>. Endeavour Silver (NYSE:<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a>) <font color=\"green\">+8%</font>. Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Independence Contract Drilling (NYSE:<a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling, Inc.'>ICD</a>) <font color=\"red\">-13%</font>. Osisko Gold Royalties (NYSE:<a href='https://seekingalpha.com/symbol/OR' title='Osisko Gold Royalties Ltd'>OR</a>) <font color=\"red\">-10%</font>. Antero Resources (NYSE:<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a>) <font color=\"red\">-8%</font>. Basic Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a>) <font color=\"red\">-8%</font>. Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501258\" data-linked=\"Contango Oil &amp; Gas and McDermott among Energy/Materials gainers; Independence Contract Drilling and Osisko Gold Royalties among losers\" data-tweet=\"$MCF $MDR $DRD - Contango Oil &amp; Gas and McDermott among Energy/Materials gainers; Independence Contract Drilling and Osisko Gold Royalties among losers https://seekingalpha.com/news/3501258-contango-oil-gas-and-mcdermott-among-energy-materials-gainers-independence-contract-drilling?source=tweet\" data-url=\"https://seekingalpha.com/news/3501258-contango-oil-gas-and-mcdermott-among-energy-materials-gainers-independence-contract-drilling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501256\" data-ts=\"1569261294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPHI\" target=\"_blank\">IPHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501256-inphi-bear-cautions-on-amazon-cuts-iphiminus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inphi bear cautions on Amazon cuts; IPHI -3%</a></h4><ul><li>Northland analyst Tim Savageaux reiterates a cautious view on the potential \"large cut\" in Amazon's 400G plans this year, which poses a \"significant risk\" to Inphi (NYSE:<a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a>).</li><li>The analyst also thinks the consensus overestimates the possible impact of the Cisco-Acacia merger on Inphi, seeing Lumentum as more likely to benefit in the near-term.</li><li>Northland maintains an Underperform rating on Inphi with a $42 target. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/IPHI/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>IPHI shares are <font color=\"red\">down 3.3%</font> to $61.38.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501256\" data-linked=\"Inphi bear cautions on Amazon cuts; IPHI -3%\" data-tweet=\"$IPHI - Inphi bear cautions on Amazon cuts; IPHI -3% https://seekingalpha.com/news/3501256-inphi-bear-cautions-on-amazon-cuts-iphiminus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3501256-inphi-bear-cautions-on-amazon-cuts-iphiminus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501254\" data-ts=\"1569260618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQIX\" target=\"_blank\">EQIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501254-stifel-praises-new-cto-hire-equinix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel praises new CTO hire at Equinix</a></h4><ul>   <li>Stifel's gone on record in support of the <a href=\"https://seekingalpha.com/news/3501059-equinix-appoints-justin-dustzadeh-cto\" target=\"_blank\">new chief technology officer</a> at Equinix (<a href=\"http://seekingalpha.com/symbol/EQIX\" target=\"_blank\">EQIX</a> <font color=\"green\">+3%</font>), a hire away from Uber.</li>    <li>Naming Justin Dustzadeh to the role is encouraging as it \"signals the ever increasing importance of technology and the role it will play in the overall data center landscape,\" Stifel says in a note.</li>    <li>Volume has surpassed daily average on Nasdaq as shares have tagged an all-time high today. They've <font color=\"green\">risen 60.7%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501254\" data-linked=\"Stifel praises new CTO hire at Equinix\" data-tweet=\"$EQIX - Stifel praises new CTO hire at Equinix https://seekingalpha.com/news/3501254-stifel-praises-new-cto-hire-equinix?source=tweet\" data-url=\"https://seekingalpha.com/news/3501254-stifel-praises-new-cto-hire-equinix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501251\" data-ts=\"1569260173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501251-jittery-trading-on-nio-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jittery trading on Nio ahead of earnings</a></h4><ul><li>Shares of Nio (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) are <font color=\"red\">down 9.05%</font> a day ahead of the Chinese automaker's earnings report.</li><li>Nio is expected to have halved its Q1 loss of $0.36 per share in Q2 off revenue of about $176M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501251\" data-linked=\"Jittery trading on Nio ahead of earnings\" data-tweet=\"$NIO - Jittery trading on Nio ahead of earnings https://seekingalpha.com/news/3501251-jittery-trading-on-nio-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3501251-jittery-trading-on-nio-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501247\" data-ts=\"1569259698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501247-c-band-alliance-members-rise-eutelsat-considers-rejoining\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">C-Band Alliance members rise as Eutelsat considers rejoining</a></h4><ul>   <li>Eutelsat (<a href='https://seekingalpha.com/symbol/EUTLY' title='Eutelsat Communications ADR'>OTCPK:EUTLY</a>) -- a high-profile <a href=\"https://seekingalpha.com/news/3496524-eutelsat-pulls-c-band-alliance\" target=\"_blank\">bailout early this month</a> from the C-Band Alliance working to monetize mid-band satellite spectrum -- has told the FCC that it <a href=\"https://advanced-television.com/2019/09/23/eutelsat-to-rejoin-c-band-alliance/\" target=\"_blank\">might rejoin the group</a>.</li>    <li>\u201cEutelsat expressed its willingness to reconsider actively participating in the CBA going forward if, among other things, the structure and management of the CBA could be altered to better represent the interests of all affected stakeholders,\" the company said.</li>    <li>In its exit, the company had said it continued to support market-driven clearing of the lower part of the 3.7 GHz-4.2 GHz band, but \"it is not in alignment with certain of the other CBA members on certain issues.\"</li>    <li>Those differences seem to concern stakeholders' roles, the \"potential allocation of a portion of the reconfiguration proceeds to the U.S. Government,\" and treating spectrum clearing costs.</li>    <li>Today, key C-Band members are higher: Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) <font color=\"green\">+3.7%</font>; SES (<a href='https://seekingalpha.com/symbol/SGBAF' title='SES S.A.'>OTCPK:SGBAF</a>) <font color=\"green\">+1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501247\" data-linked=\"C-Band Alliance members rise as Eutelsat considers rejoining\" data-tweet=\"$EUTLY $I $SGBAF - C-Band Alliance members rise as Eutelsat considers rejoining https://seekingalpha.com/news/3501247-c-band-alliance-members-rise-eutelsat-considers-rejoining?source=tweet\" data-url=\"https://seekingalpha.com/news/3501247-c-band-alliance-members-rise-eutelsat-considers-rejoining\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501239\" data-ts=\"1569258942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TELDF\" target=\"_blank\">TELDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501239-telefonica-deutschland-up-amid-credit-suisse-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telefónica Deutschland up amid Credit Suisse upgrade</a></h4><ul>   <li>Telefónica Deutschland (<a href='https://seekingalpha.com/symbol/TELDF' title='Telefónica Deutschland Holding AG'>OTCPK:TELDF</a>) is <font color=\"green\">up 9.6%</font> in OTC trading, on low volume, after a boost to Neutral at Credit Suisse.</li>    <li>The firm raised its price target to \u20ac2.50 from \u20ac2.30; the stock closed at \u20ac2.50 today.</li>    <li>Seeking Alpha contributor the Investment Doctor this summer <a href=\"https://seekingalpha.com/article/4275215-pro-exclusive-telefonica-deutschland-even-cash-flows-indicate-12-percent-dividend-sustainable\" target=\"_blank\">stayed bullish</a> on the German provider despite the fact that the dividend (and a double-digit yield) didn't look sustainable.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501239\" data-linked=\"Telefónica Deutschland up amid Credit Suisse upgrade\" data-tweet=\"$TELDF - Telefónica Deutschland up amid Credit Suisse upgrade https://seekingalpha.com/news/3501239-telefonica-deutschland-up-amid-credit-suisse-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3501239-telefonica-deutschland-up-amid-credit-suisse-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501231\" data-ts=\"1569258177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELOX\" target=\"_blank\">ELOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501231-cf-foundation-to-support-eloxx-pharma-mid-stage-elxminus-02-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CF Foundation to support Eloxx Pharma mid-stage ELX-02 study</a></h4><ul><li>Thinly traded micro cap Eloxx Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ELOX' title='Eloxx Pharmaceuticals, Inc.'>ELOX</a> <font color=\"red\">-7%</font>) is down on average volume, a modest 81K shares, after <a href=\"https://seekingalpha.com/pr/17639803-eloxx-pharmaceuticals-announces-cystic-fibrosis-foundation-cf-foundation-provide-funding\" target=\"_blank\">announcing </a>that the Cystic Fibrosis &#40;CF&#41; Foundation will provide up to $1.6M to support a U.S.-based eight-subject Phase 2 clinical trial, EL-012, evaluating multiple doses of ELX-02 in CF patients with at least one G542X allele.</li><li>A study in Europe, EL-004, will enroll up to 16 participants.</li><li>Topline results from both should be available in Q4.</li><li><a href=\"https://www.eloxxpharma.com/pipeline/\" target=\"_blank\">ELX-02</a> is a eukaryotic ribosomal selective glycoside, a molecule that modulates the ribosome, a part of the cell that plays a major role in protein production. It is designed to increase the read-through activity in patients with nonsense mutations, enabling the production of enough full-length protein to restore biochemical activity. CF is caused by the absence of or dysfunction in a protein called CFTR resulting from mutations in the gene that encodes the protein.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501231\" data-linked=\"CF Foundation to support Eloxx Pharma mid-stage ELX-02 study\" data-tweet=\"$ELOX - CF Foundation to support Eloxx Pharma mid-stage ELX-02 study https://seekingalpha.com/news/3501231-cf-foundation-to-support-eloxx-pharma-mid-stage-elxminus-02-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3501231-cf-foundation-to-support-eloxx-pharma-mid-stage-elxminus-02-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501229\" data-ts=\"1569258025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501229-arotech-only-industrial-gainer-charah-solutions-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arotech only industrial gainer; Charah Solutions only loser</a></h4><ul><li><b>Gainers: </b>Arotech (NASDAQ:<a href='https://seekingalpha.com/symbol/ARTX' title='Arotech Corporation'>ARTX</a>) <font color=\"green\">+31%</font>.</li><li><b>Losers: </b>Charah Solutions (NYSE:<a href='https://seekingalpha.com/symbol/CHRA' title='Charah Solutions, Inc.'>CHRA</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501229\" data-linked=\"Arotech only industrial gainer; Charah Solutions only loser\" data-tweet=\"$ARTX $CHRA - Arotech only industrial gainer; Charah Solutions only loser https://seekingalpha.com/news/3501229-arotech-only-industrial-gainer-charah-solutions-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3501229-arotech-only-industrial-gainer-charah-solutions-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501226\" data-ts=\"1569257616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501226-palomar-holdings-leads-financial-gainers-ashford-and-yirendai-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palomar Holdings leads financial gainers, Ashford and Yirendai among losers</a></h4><ul><li><b>Gainers:</b> Palomar Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PLMR' title='Palomar Holdings, Inc.'>PLMR</a>) <font color=\"green\">+7%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"green\">+7%</font>. ICICI Bank (NYSE:<a href='https://seekingalpha.com/symbol/IBN' title='ICICI Bank Limited'>IBN</a>) <font color=\"green\">+6%</font>. Hallmark Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/HALL' title='Hallmark Financial Services, Inc.'>HALL</a>) <font color=\"green\">+6%</font>. Impac Mortgage Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/IMH' title='Impac Mortgage Holdings, Inc.'>IMH</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Medallion Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a>) <font color=\"red\">-10%</font>. Ashford (NYSEMKT:<a href='https://seekingalpha.com/symbol/AINC' title='Ashford Inc.'>AINC</a>) <font color=\"red\">-9%</font>. OptimumBank Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a>) <font color=\"red\">-6%</font>. Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai Ltd.'>YRD</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501226\" data-linked=\"Palomar Holdings leads financial gainers, Ashford and Yirendai among losers\" data-tweet=\"$PLMR $CBL $IBN - Palomar Holdings leads financial gainers, Ashford and Yirendai among losers https://seekingalpha.com/news/3501226-palomar-holdings-leads-financial-gainers-ashford-and-yirendai-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501226-palomar-holdings-leads-financial-gainers-ashford-and-yirendai-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501213\" data-ts=\"1569256410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501213-healthcare-and-technology-names-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare and Technology names dominate midday movers</a></h4><ul><li><strong>Gainers:</strong> Interlink Electronics (<a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics, Inc.'>OTCPK:LINK</a>) <font color=\"green\">+37%</font>. Avadel Pharmaceuticals plc (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <font color=\"green\">+33%</font>. Arotech Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/ARTX' title='Arotech Corporation'>ARTX</a>) <font color=\"green\">+31%</font>. Plus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a>) <font color=\"green\">+25%</font>. Cesca Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc.'>KOOL</a>) <font color=\"green\">+20%</font>. PriceSmart (NASDAQ:<a href='https://seekingalpha.com/symbol/PSMT' title='PriceSmart, Inc.'>PSMT</a>) <font color=\"green\">+18%</font>. Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+16%</font>. VirTra (NASDAQ:<a href='https://seekingalpha.com/symbol/VTSI' title='VirTra, Inc.'>VTSI</a>) <font color=\"green\">+14%</font>. Contango Oil &amp; Gas Company (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"green\">+14%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"green\">+14%</font>.</li><li><strong>Losers: </strong>Reebonz Holding Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"red\">-36%</font>. Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics, Inc.'>ONTX</a>) <font color=\"red\">-23%</font>. Akcea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics, Inc.'>AKCA</a>) <font color=\"red\">-20%</font>. Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <font color=\"red\">-16%</font>. Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) <font color=\"red\">-14%</font>. IRIDEX Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/IRIX' title='IRIDEX Corporation'>IRIX</a>) <font color=\"red\">-13%</font>. Independence Contract Drilling (NYSE:<a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling, Inc.'>ICD</a>) <font color=\"red\">-13%</font>. Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"red\">-12%</font>. Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a>) <font color=\"red\">-11%</font>. Kratos Defense &amp; Security Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOS' title='Kratos Defense & Security Solutions, Inc.'>KTOS</a>) <font color=\"red\">-11%</font>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3501213\" data-linked=\"Healthcare and Technology names dominate midday movers\" data-tweet=\"$LINK $AVDL $ARTX - Healthcare and Technology names dominate midday movers https://seekingalpha.com/news/3501213-healthcare-and-technology-names-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501213-healthcare-and-technology-names-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501200\" data-ts=\"1569254894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOVA\" target=\"_blank\">DOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501200-dova-pharma-up-17-bulls-move-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dova Pharma up 17% as bulls move in</a></h4><ul><li>Dova Pharmaceuticals (<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a> <font color=\"green\">+17.4%</font>) is up on average volume in apparent response to a bullish report from Wedbush centered on lead drug Doptelet (avatrombopag), approved in the U.S. in May 2018 for chronic liver disease &#40;CLD&#41; patients with thrombocytopenia (low blood platelets) who are undergoing a procedure and in June 2019 for patients with chronic immune thrombocytopenia &#40;ITP&#41;.</li><li>The company launched the thrombopoietin agonist in the U.S. in June 2018 for the CLD indication and 11 months later for the ITP indication. 60 direct sales reps are now in place.</li><li>H1 sales were $7.5M (+284%).</li><li>Topline data from a study in chemo-induced thrombocytopenia should be available in H1 2020.</li><li>SA Authors rate the stock <a href=\"https://seekingalpha.com/symbol/DOVA/ratings/author-ratings#filter=all\" target=\"_blank\">Very Bullish</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501200\" data-linked=\"Dova Pharma up 17% as bulls move in\" data-tweet=\"$DOVA - Dova Pharma up 17% as bulls move in https://seekingalpha.com/news/3501200-dova-pharma-up-17-bulls-move-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3501200-dova-pharma-up-17-bulls-move-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501198\" data-ts=\"1569254807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAM\" target=\"_blank\">SAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501198-boston-beerplus-3-after-guggenheim-points-to-momentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Beer +3% after Guggenheim points to momentum</a></h4><ul><li>Boston Beer gains (<a href='https://seekingalpha.com/symbol/SAM' title='The Boston Beer Company, Inc.'>SAM</a> <font color=\"green\">+2.7%</font>) after Guggenheim <a href=\"https://www.cnbc.com/2019/09/23/stocks-making-the-biggest-moves-midday-boston-beer-chewy-overstock.html\" target=\"_blank\">lifts</a> its price target to $462 from $449 per share due to continued momentum of spiked seltzer brand Truly. The Guggenheim PT on Boston Beer is well-ahead of the consensus PT of <a href=\"https://seekingalpha.com/symbol/SAM/ratings/sell-side-ratings\" target=\"_blank\">$361.43</a> and above the 52-week high of $444.64.</li><li>The Guggenheim analysts team thinks Truly is making up ground on privately-owned hard seltzer brand White Claw.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501198\" data-linked=\"Boston Beer +3% after Guggenheim points to momentum\" data-tweet=\"$SAM - Boston Beer +3% after Guggenheim points to momentum https://seekingalpha.com/news/3501198-boston-beerplus-3-after-guggenheim-points-to-momentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3501198-boston-beerplus-3-after-guggenheim-points-to-momentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501197\" data-ts=\"1569254704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501197-borderlands-3-passes-5m-units-in-five-days-on-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Borderlands 3&#39; passes 5M units in five days on sale</a></h4><ul>   <li><em>Borderlands 3</em> sell-in <a href=\"https://seekingalpha.com/pr/17639856-borderlands-3-redefines-mayhem-establishes-franchise-billion-dollar-global-brand\" target=\"_blank\">passed 5M units</a> within five days of launch, marking the fastest-selling title in Take-Two (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color=\"red\">-3.1%</font>) history.</li>    <li>It also became the publisher's highest-selling PC title ever, the company says.</li>    <li>The numbers are up 50% in that time frame over predecessor <em>Borderlands 2.</em></li>    <li>The <em>Borderlands</em> franchise has now generated more than $1B in net bookings.</li>    <li>More than 70% of consumers bought the game digitally, and it delivered the highest preorder sales figure for a 2K title to date.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501197\" data-linked=\"&#39;Borderlands 3&#39; passes 5M units in five days on sale\" data-tweet=\"$TTWO - &#39;Borderlands 3&#39; passes 5M units in five days on sale https://seekingalpha.com/news/3501197-borderlands-3-passes-5m-units-in-five-days-on-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3501197-borderlands-3-passes-5m-units-in-five-days-on-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501193\" data-ts=\"1569254451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501193-steelcase-and-caleres-among-consumer-gainers-nio-and-calyxt-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steelcase and Caleres among consumer gainers; NIO and Calyxt among losers</a></h4><ul><li><b>Gainers: </b>Vince Holding (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) <font color=\"green\">+6%</font>. Pingtan Marine Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) <font color=\"green\">+6%</font>. Sportsman's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>) <font color=\"green\">+6%</font>. Steelcase (NYSE:<a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a>) <font color=\"green\">+6%</font>. Caleres (NYSE:<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Ennis (NYSE:<a href='https://seekingalpha.com/symbol/EBF' title='Ennis, Inc.'>EBF</a>) <font color=\"red\">-9%</font>. Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future FinTech Group Inc.'>FTFT</a>) <font color=\"red\">-8%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"red\">-7%</font>. Calyxt (NASDAQ:<a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501193\" data-linked=\"Steelcase and Caleres among consumer gainers; NIO and Calyxt among losers\" data-tweet=\"$VNCE $PME $SPWH - Steelcase and Caleres among consumer gainers; NIO and Calyxt among losers https://seekingalpha.com/news/3501193-steelcase-and-caleres-among-consumer-gainers-nio-and-calyxt-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501193-steelcase-and-caleres-among-consumer-gainers-nio-and-calyxt-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501194\" data-ts=\"1569254310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501194-purecircleminus-4_2-post-h1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PureCircle -4.2% post H1 results</a></h4><ul><li>Purecircle (<a href='https://seekingalpha.com/symbol/PCRTF' title='PureCircle Limited'>OTCPK:PCRTF</a> <font color=\"red\">-4.2%</font>) reported <a href=\"http://otp.investis.com/clients/uk/pure-circle/rns/regulatory-story.aspx?cid=206&amp;newsid=1239311\" target=\"_blank\">H1</a> revenue of $50.7M, a decrease of 5.2% Y/Y.</li><li>Gross margin <font color=\"green\">increased 240 bps</font> to 39.2%; operating margin <font color=\"green\">increased 1,630 bps</font> to 22.1% and Adj. EBITDA margin too <font color=\"green\">increased 830 bps</font> to 22.8%.</li><li>Net debt of $103.5M has increased due to working capital requirements, additional research &amp; development costs and fixed assets.</li><li>No dividends were declared or paid by the Company during the interim period.</li><li>During the period there was a significant inventory write down to net realisable value of $24.2M primarily relating to by-products generated from early generations of stevia leaf.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441802-purecircle-reports-1h-results\" target=\"_blank\">Purecircle reports 1H results</a> (Mar. 12 2019).</li></ul><div class=\"tiny-share-widget\" data-id=\"3501194\" data-linked=\"PureCircle -4.2% post H1 results\" data-tweet=\"$PCRTF - PureCircle -4.2% post H1 results https://seekingalpha.com/news/3501194-purecircleminus-4_2-post-h1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3501194-purecircleminus-4_2-post-h1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501191\" data-ts=\"1569254079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORK\" target=\"_blank\">WORK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501191-slackminus-5-after-bernstein-guidance-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slack -5% after Bernstein guidance warning</a></h4><ul><li>Bernstein says Slack (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) may have given a \"softball\" Q3 forecast, which could set a difficult precedent.</li><li>Analyst Mark Moerdler says the forecast either shows growth is rapidly slowing or management set the outlook low to achieve a comfortable beat.</li><li>Moerdler says that tactic sets \"investor expectations of strong beats for the future which may be difficult to deliver beyond the next quarter or two given increasing competition and a trajectory of slowing revenue growth.\"</li><li>Bernstein maintains a Market Perform rating and $28 target. Slack has a Neutral average <a href=\"https://seekingalpha.com/symbol/WORK/ratings/author-ratings#filter=all\" target=\"_blank\">Sell Side rating</a>.</li><li>Slack shares are <font color=\"red\">down 5.2%</font> to $24.06.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501191\" data-linked=\"Slack -5% after Bernstein guidance warning\" data-tweet=\"$WORK - Slack -5% after Bernstein guidance warning https://seekingalpha.com/news/3501191-slackminus-5-after-bernstein-guidance-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3501191-slackminus-5-after-bernstein-guidance-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501187\" data-ts=\"1569253675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVEO\" target=\"_blank\">AVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501187-aveo-pharma-up-4-on-tivozanib-data-in-kidney-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aveo Pharma up 4% on tivozanib data in kidney cancer</a></h4><ul><li>AVEO Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color=\"green\">+3.5%</font>) is up on below-average volume following the release of <a href=\"https://seekingalpha.com/pr/17639714-aveo-oncology-eusa-pharma-announce-presentation-final-pfs-results-phase-2-portion-tinivo\" target=\"_blank\">final results</a> from the Phase 2 portion of its <a href=\"https://clinicaltrials.gov/ct2/show/NCT03136627?lead=aveo+pharmaceuticals&amp;rank=2\" target=\"_blank\">Phase 1b/2 clinical trial</a> evaluating the combination of Fotivda (tivozanib) and Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"green\">+0.8%</font>) Opdivo (nivolumab) in patients with advanced/metastatic renal cell carcinoma. The results will be presented at ESMO in Barcelona.</li><li>The objective response rate &#40;ORR&#41; was 56% (n=14/25), including one complete responder. The disease control rate (responders + stable cancer) was 96% (n=24/25). Median progression-free survival &#40;PFS&#41; was 18.9 months.</li><li>On the safety front, the most common serious/life-threatening adverse event was hypertension (high blood pressure).</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501187\" data-linked=\"Aveo Pharma up 4% on tivozanib data in kidney cancer\" data-tweet=\"$AVEO $BMY - Aveo Pharma up 4% on tivozanib data in kidney cancer https://seekingalpha.com/news/3501187-aveo-pharma-up-4-on-tivozanib-data-in-kidney-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3501187-aveo-pharma-up-4-on-tivozanib-data-in-kidney-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501185\" data-ts=\"1569253335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CS\" target=\"_blank\">CS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501185-credit-suisseminus-1_7-amid-swiss-probe-involving-banker-private-detectives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse -1.7% amid Swiss probe involving banker, private detectives</a></h4><ul><li>Credit Suisse (NYSE:<a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a>) <font color=\"red\">slips 1.7%</font> after Swiss prosecutors<a href=\"https://www.reuters.com/article/us-credit-suisse-khan/swiss-probe-incident-involving-ex-credit-suisse-banker-khan-private-detectives-idUSKBN1W817E\" target=\"_blank\"> open a criminal investigation</a> into allegations that bank hired private detectives to follow Iqbal Khan, who had led the bank's wealth management unit.</li><li>Khan will head the wealth management unit at Credit Suisse's rival UBS (<a href='https://seekingalpha.com/symbol/UBS' title='UBS Group AG'>UBS</a> <font color='red'>-1.1%</font>) in October, three months after leaving CS.</li><li>SonntagsZeitung, a Swiss newspaper, reported on Sunday that Credit Suisse had hired three detectives to investigate whether Khan was seeking to poach Credit Suisse employees for UBS.</li><li>The Zurich District Attorney opened the probe after Khan had filed a criminal complaint alleging threats and coercion in a Sept. 17 incident, but didn't say who made the threats or what they were.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501185\" data-linked=\"Credit Suisse -1.7% amid Swiss probe involving banker, private detectives\" data-tweet=\"$CS $UBS - Credit Suisse -1.7% amid Swiss probe involving banker, private detectives https://seekingalpha.com/news/3501185-credit-suisseminus-1_7-amid-swiss-probe-involving-banker-private-detectives?source=tweet\" data-url=\"https://seekingalpha.com/news/3501185-credit-suisseminus-1_7-amid-swiss-probe-involving-banker-private-detectives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501176\" data-ts=\"1569252210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OVID\" target=\"_blank\">OVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501176-ovid-up-7-on-positive-soticlestat-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ovid up 7% on positive soticlestat data</a></h4><ul><li>Thinly traded nano cap Ovid Therapeutics (<a href='https://seekingalpha.com/symbol/OVID' title='Ovid Therapeutics Inc.'>OVID</a> <font color=\"green\">+6.7%</font>) is up on below-average volume on the heels of <a href=\"https://seekingalpha.com/pr/17639762-ovid-therapeutics-announces-positive-initial-data-ongoing-endymion-open-label-extension-trial\" target=\"_blank\">preliminary results</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03635073?term=ovid+therapeutics&amp;rank=6\" target=\"_blank\">Phase 2 open-label extension study</a> evaluating soticlestat (OV925/TAK-935) in patients with rare developmental and epileptic encephalopathies, including Dravet syndrome and Lennox-Gastaut syndrome.</li><li>Data up to 48 weeks suggest increased seizure reduction with prolonged treatment. Median seizure reductions were 84% following weeks 25-36 (n=6) and 90% following weeks 37-48 (n=4). The longest seizure-free period for any one patient was 264 days.</li><li>Preliminary data from the Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03694275?term=ovid+therapeutics&amp;rank=7\" target=\"_blank\">ARCADE </a>study should be available in Q1 2020 followed by topline results from Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03650452?term=ovid+therapeutics&amp;rank=5\" target=\"_blank\">ELEKTRA </a>in H2 2020.</li><li>Soticlestat inhibits an enzyme called cholesterol 24-hydroxylase (CH24H) which converts cholesterol into 24HC. CH24H plays a key role in the over-activation in a certain metabolic pathway related to CNS disorders like epilepsy.</li><li>The company is co-developing the candidate with Takeda Pharmaceutical Company (<a href='https://seekingalpha.com/symbol/TAK' title='Takeda Pharmaceutical Company Limited'>TAK</a> <font color=\"green\">+0.2%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3501176\" data-linked=\"Ovid up 7% on positive soticlestat data\" data-tweet=\"$OVID $TAK - Ovid up 7% on positive soticlestat data https://seekingalpha.com/news/3501176-ovid-up-7-on-positive-soticlestat-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3501176-ovid-up-7-on-positive-soticlestat-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501175\" data-ts=\"1569252170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRBK\" target=\"_blank\">GRBK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501175-btig-boosts-price-targets-for-d-r-horton-lennar-upgrades-green-brick\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BTIG boosts price targets for D.R. Horton, Lennar; upgrades Green Brick</a></h4><ul><li>BTIG analyst Carl Reichardt boosts price targets for most of the homebuilders he covers and upgrades Green Brick Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/GRBK' title='Green Brick Partners, Inc.'>GRBK</a>) to buy from neutral as positive order trends leads him to adopt a brighter outlook for H2.</li><li>Nevertheless, Green Brick <font color=\"red\">falls 4.0%</font>.</li><li>Reichardt boosts price target for D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D.R. Horton, Inc.'>DHI</a> <font color='green'>+1.5%</font>) to Street-high of $62 from $56 and Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='green'>+0.6%</font>) to $70 from $65, noting the two companies are in the best position to benefit from better demand, boost order growth, and return capital.</li><li>The housing slowdown that started in H2 2018 was shallower than BTIG originally expected as the industry was helped by \"lower interest rates, aggressive price cuts and incentives, and a mix shift to more affordable product,\" Reichardt wrotes.</li><li>Quant rating for Green Brick is <a href=\"https://seekingalpha.com/symbol/GRBK/ratings/quant-ratings?s=grbk\" target=\"_blank\">Very Bullish</a>; before this action, average Sell-Side rating was <a href=\"https://seekingalpha.com/symbol/GRBK/ratings/sell-side-ratings\" target=\"_blank\">Hold</a> (1 Outperform, 2 Hold).</li><li>In the past six months, <a href=\"https://seekingalpha.com/symbol/GRBK/momentum/performance\" target=\"_blank\">Green Brick has risen </a>21% vs. consumer discretionary sector median performance of -3.9% during that same period.</li><li>Quant rating for D.R. Horton is<a href=\"https://seekingalpha.com/symbol/DHI/ratings/quant-ratings?s=dhi\" target=\"_blank\"> Very Bullish</a> an for Lennar is <a href=\"https://seekingalpha.com/symbol/LEN/ratings/quant-ratings?s=len\" target=\"_blank\">Bullish</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501175\" data-linked=\"BTIG boosts price targets for D.R. Horton, Lennar; upgrades Green Brick\" data-tweet=\"$GRBK $DHI $LEN - BTIG boosts price targets for D.R. Horton, Lennar; upgrades Green Brick https://seekingalpha.com/news/3501175-btig-boosts-price-targets-for-d-r-horton-lennar-upgrades-green-brick?source=tweet\" data-url=\"https://seekingalpha.com/news/3501175-btig-boosts-price-targets-for-d-r-horton-lennar-upgrades-green-brick\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501173\" data-ts=\"1569251447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501173-dhx-media-rallies-12_5-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DHX Media rallies 12.5% post Q4 results</a></h4><ul><li>DHX Media (<a href='https://seekingalpha.com/symbol/DHXM' title='DHX Media Ltd.'>DHXM</a> <font color=\"green\">+12.5%</font>) reported <a href=\"https://seekingalpha.com/pr/17639733-dhx-media-reports-q4-full-year-fiscal-2019-results-announces-name-change-wildbrain\" target=\"_blank\">Q4</a> revenue of C$108.8M, an increase of 11.7% Y/Y.</li><li>Distribution revenue grew 46% Y/Y to C$16.6M and Consumer products-owned revenue grew 22% Y/Y to C$38.6M, driven by Peanuts.</li><li>Wildbrain revenue grew by 25% Y/Y to C$17.9M and views increased 29% to 9.3B.</li><li>Q4 Gross margin <font color=\"green\">increased 100 bps</font> to 44% and Adj. EBITDA margin too <font color=\"green\">increased 214 bps</font> to 18.6%.</li><li>Company signed a worldwide exclusive agreement to create new Peanuts content for Apple, which is expected to contribute steady EBITDA for the coming years.</li><li>The company paid C$223.8M on the term loan and C$16.4M on the revolving credit facility during Fiscal 2019.</li><li>Net debt declined to C$494.1M, resulting in the net leverage ratio decreasing to 5.92x at June 30, 2019.</li><li>Also, sold a building in Toronto for gross proceeds of C$12M to pay down a portion of the Company's term loan.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3501031-dhx-media-beats-revenue\" target=\"_blank\">DHX Media beats on revenue</a> (Sep. 23 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3501173\" data-linked=\"DHX Media rallies 12.5% post Q4 results\" data-tweet=\"$DHXM - DHX Media rallies 12.5% post Q4 results https://seekingalpha.com/news/3501173-dhx-media-rallies-12_5-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3501173-dhx-media-rallies-12_5-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501165\" data-ts=\"1569250902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501165-plus-therapeutics-leads-healthcare-gainers-akcea-therapeutics-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plus Therapeutics leads healthcare gainers; Akcea Therapeutics leads the losers</a></h4><ul><li><b>Gainers: </b>Plus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a>) <font color=\"green\">+43%</font>. Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <font color=\"green\">+25%</font>. Cesca Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc.'>KOOL</a>) <font color=\"green\">+18%</font>. Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals, Inc.'>DOVA</a>) <font color=\"green\">+14%</font>. Checkpoint Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CKPT' title='Checkpoint Therapeutics, Inc.'>CKPT</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>Akcea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics, Inc.'>AKCA</a>) <font color=\"red\">-23%</font>. Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics, Inc.'>ONTX</a>) <font color=\"red\">-23%</font>. IRIDEX (NASDAQ:<a href='https://seekingalpha.com/symbol/IRIX' title='IRIDEX Corporation'>IRIX</a>) <font color=\"red\">-14%</font>. Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <font color=\"red\">-12%</font>. Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"red\">-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501165\" data-linked=\"Plus Therapeutics leads healthcare gainers; Akcea Therapeutics leads the losers\" data-tweet=\"$PSTV $AVDL $THMO - Plus Therapeutics leads healthcare gainers; Akcea Therapeutics leads the losers https://seekingalpha.com/news/3501165-plus-therapeutics-leads-healthcare-gainers-akcea-therapeutics-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501165-plus-therapeutics-leads-healthcare-gainers-akcea-therapeutics-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501164\" data-ts=\"1569250545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501164-micron-bull-expects-profitable-bottom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron bull expects profitable bottom</a></h4><ul><li>Credit Suisse analyst John Pitzer expects Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a> <font color='green'>+1.5%</font>) to report its first profitable cycle bottom this week.</li><li>Pitzer forecasts $4.6-4.8B in revenue with $0.60-0.65 EPS, which are above consensus.</li><li>The analyst says the combination of profit and the supply/demand dynamic driving EPS potential for 18-24 months \"should provide ample multiple expansion.\"</li><li>Credit Suisse maintains an Outperform rating and $90 price target. Micron has an Outperform average <a href=\"https://seekingalpha.com/symbol/MU/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Micron will <a href=\"https://seekingalpha.com/symbol/MU/ratings/sell-side-ratings\" target=\"_blank\">report earning</a>s on September 26.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501164\" data-linked=\"Micron bull expects profitable bottom\" data-tweet=\"$MU - Micron bull expects profitable bottom https://seekingalpha.com/news/3501164-micron-bull-expects-profitable-bottom?source=tweet\" data-url=\"https://seekingalpha.com/news/3501164-micron-bull-expects-profitable-bottom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>86&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501152\" data-ts=\"1569249482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501152-opko-health-up-4-on-long-term-somatrogon-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opko Health up 4% on long-term somatrogon data</a></h4><ul><li>OPKO Health (<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color=\"green\">+3.5%</font>) is up on below-average volume on the heels of <a href=\"https://www.sec.gov/Archives/edgar/data/944809/000094480919000060/a8khghctpex991.htm\" target=\"_blank\">long-term safety data</a> on once-weekly somatrogon (hGH-CTP) in children with growth hormone deficiency.</li><li>Results from a Phase 2 extension study showed a safety profile on par with the 12-month Phase 2 trial and daily r-hGH. There was only one serious adverse event, exacerbation of thoracic scoliosis (sideways curvature of the spine in the thoracic area), that was probably treatment-related.</li><li>On the efficacy front, three-year data showed height normalization over time.</li><li>Collaboration partner Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"red\">-0.7%</font>) is responsible for regulatory filings and commercialization.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501152\" data-linked=\"Opko Health up 4% on long-term somatrogon data\" data-tweet=\"$OPK $PFE - Opko Health up 4% on long-term somatrogon data https://seekingalpha.com/news/3501152-opko-health-up-4-on-long-term-somatrogon-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3501152-opko-health-up-4-on-long-term-somatrogon-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501150\" data-ts=\"1569248662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSMT\" target=\"_blank\">PSMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501150-pricesmart-pops-to-10-month-high-off-index-inclusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PriceSmart pops to 10-month high off index inclusion</a></h4><ul> <li>PriceSmart (<a href='https://seekingalpha.com/symbol/PSMT' title='PriceSmart, Inc.'>PSMT</a> <font color='green'>+15.3%</font>) soars on news that it will be <a href=\"https://seekingalpha.com/news/3500963-nvr-joining-s-and-p-500-psmt-plus-1_3-percent-joins-smallcap-600\" target=\"_blank\">added</a> to the SmallCap 600 Index.</li> <li>Shares of PriceSmart cracked $70 for the first time since last November earlier in the session.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3501150\" data-linked=\"PriceSmart pops to 10-month high off index inclusion\" data-tweet=\"$PSMT - PriceSmart pops to 10-month high off index inclusion https://seekingalpha.com/news/3501150-pricesmart-pops-to-10-month-high-off-index-inclusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3501150-pricesmart-pops-to-10-month-high-off-index-inclusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501149\" data-ts=\"1569248464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501149-alcoa-schnitzer-steel-commercial-metals-all-cut-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa, Schnitzer Steel, Commercial Metals all cut at Goldman</a></h4><ul><li>Alcoa (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-1.7%</font>) opens lower after Goldman Sachs <a href=\"https://thefly.com/landingPageNews.php?id=2966201&amp;headline=CMC;SCHN;AA-Alcoa-downgraded-to-Neutral-from-Buy-at-Goldman-Sachs\" target=\"_blank\">downgrades</a> shares to Neutral from Buy with a $25 price target, trimmed from $30, as analyst Matthew Korn cites expectations of lower aluminum and alumina prices in the near term and few company-specific catalysts in sight.</li><li>Additional upside in Alcoa shares will be limited without a \"substantial, better than expected\" move in aluminum and alumina prices, Korn says, adding that a slowing China, growing U.S. steel capacity and fears of global recession will continue to worry metals and mining investors.</li><li>Korn also cuts Schnitzer Steel (<a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a> <font color='red'>-8.5%</font>) to Sell from Neutral and Commercial Metals (<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='red'>-0.2%</font>) to Neutral from Buy.</li><li>On SCHN, Korn thinks the company has done a good job in diversifying its geographical market, upgrading the quality of its scrap offerings and improving operational efficiency, but scrap markets are now showing signs of further weakening, and he is concerned that deteriorating conditions add risk to SCHN's earnings profile.</li><li>AA's average <a href=\"https://seekingalpha.com/symbol/AA/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, while both its <a href=\"https://seekingalpha.com/symbol/AA/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> and <a href=\"https://seekingalpha.com/symbol/AA/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501149\" data-linked=\"Alcoa, Schnitzer Steel, Commercial Metals all cut at Goldman\" data-tweet=\"$AA $SCHN $CMC - Alcoa, Schnitzer Steel, Commercial Metals all cut at Goldman https://seekingalpha.com/news/3501149-alcoa-schnitzer-steel-commercial-metals-all-cut-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/3501149-alcoa-schnitzer-steel-commercial-metals-all-cut-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501143\" data-ts=\"1569247493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501143-beyond-meat-slides-new-bear-steps-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat slides as new bear steps out</a></h4><ul> <li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) is <font color=\"red\">down 4.52%</font> in early trading after a downgrade arrives from across the Atlantic Ocean.</li> <li>Exane BNP Paribas initiates coverage on Beyond Meat with an Underperform rating and price target of $70 (more than 50% downside).</li> <li>\"While plant-based meats will grow rapidly, we believe that barriers to entry are negligible; we thus struggle to justify BYND's valuation,\" notes the French firm.</li> <li>As noted by others, major players like Kellog, Nestle and Tyson are all active in the next-gen protein space, warns Exane.</li> <li>A majority of sell-side firms are cruising along with a Hold-equivalent <a href=\"https://seekingalpha.com/symbol/BYND/ratings/sell-side-ratings\" target=\"_blank\">rating</a> on Beyond Meat amid the high-volatility action.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501143\" data-linked=\"Beyond Meat slides as new bear steps out\" data-tweet=\"$BYND - Beyond Meat slides as new bear steps out https://seekingalpha.com/news/3501143-beyond-meat-slides-new-bear-steps-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3501143-beyond-meat-slides-new-bear-steps-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501142\" data-ts=\"1569247416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRSP\" target=\"_blank\">PRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501142-perspecta-receives-657m-navy-contract-extension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perspecta receives $657M Navy contract extension</a></h4><ul><li>Perspecta (NYSE:<a href='https://seekingalpha.com/symbol/PRSP' title='Perspecta Inc.'>PRSP</a>) <a href=\"https://seekingalpha.com/pr/17640088-u-s-department-navy-awards-perspecta-657-million-extension-continue-providing-services-next\" target=\"_blank\">announces</a> the extension of its NGEN contract with the U.S. Department of the Navy for continued delivery IT services.</li><li>The extension adds four months to the current delivery period, pushing the date back to September 30, 2020. Three one-month options are available.</li><li>PRSP shares are <font color=\"red\">down 1.7%</font> to $25.88.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501142\" data-linked=\"Perspecta receives $657M Navy contract extension\" data-tweet=\"$PRSP - Perspecta receives $657M Navy contract extension https://seekingalpha.com/news/3501142-perspecta-receives-657m-navy-contract-extension?source=tweet\" data-url=\"https://seekingalpha.com/news/3501142-perspecta-receives-657m-navy-contract-extension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501137\" data-ts=\"1569247184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSSS\" target=\"_blank\">SSSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501137-value-of-sutter-rocks-palantir-holding-may-rise-on-new-fundraising-btig\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Value of Sutter Rock&#39;s Palantir holding may rise on new fundraising - BTIG</a></h4><ul><li>BTIG analyst Mark Palmer says a <a href=\"https://www.reuters.com/article/us-palantir-fundraising-exclusive/exclusive-palantir-to-seek-at-least-26-billion-valuation-in-fundraising-sources-idUSKBN1W52F7\" target=\"_blank\">Reuters report </a>that Palantir Technologies (<a href='https://seekingalpha.com/symbol/PALAN' title='Palantir Technologies'>PALAN</a>) is seeking funding that would value the company at $26B-$30B shows <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=bjchhk-b\" target=\"_blank\">how conservatively</a> Sutter Rock Capital's (<a href='https://seekingalpha.com/symbol/SSSS' title='Sutter Rock Capital Corp.'>SSSS</a> <font color=\"green\">+1.1%</font>) holdings in Palantir are marked on its books and how inexpensive Sutter Rock is relative to the inherent value of its portfolio of late-stage venture investments.</li><li>Sutter Rock's position in Palantir, the largest of its investment portfolio as of June 30, had a listed fair value of $30.7M, or $5.31 per share, and represented 16.7% of its holdings.</li><li>With 19.7M shares outstanding at SSSS, if Palantir were to price in the reported range, it would add between $2.00 and $2.54 to the company\u2019s net asset value per share, according to BTIG's estimates.</li><li>As of June 30, 2019, Sutter Rock's NAV was $10.75. At Friday's close, SSSS was $6.40, or just under 60% of its NAV.</li><li>Palmer reiterates buy recommendation and price target of $11.50.</li><li>Sutter Rock's Quant rating is<a href=\"https://seekingalpha.com/symbol/SSSS/ratings/quant-ratings\" target=\"_blank\"> Neutral</a>; Sell-Side average rating is<a href=\"https://seekingalpha.com/symbol/SSSS/ratings/sell-side-ratings\" target=\"_blank\"> Buy</a> (3 Buy, 1 Outperform).</li></ul><div class=\"tiny-share-widget\" data-id=\"3501137\" data-linked=\"Value of Sutter Rock&#39;s Palantir holding may rise on new fundraising - BTIG\" data-tweet=\"$SSSS $PALAN $PALAN - Value of Sutter Rock&#39;s Palantir holding may rise on new fundraising - BTIG https://seekingalpha.com/news/3501137-value-of-sutter-rocks-palantir-holding-may-rise-on-new-fundraising-btig?source=tweet\" data-url=\"https://seekingalpha.com/news/3501137-value-of-sutter-rocks-palantir-holding-may-rise-on-new-fundraising-btig\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501133\" data-ts=\"1569246906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAG\" target=\"_blank\">AMAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501133-fda-advisory-committee-to-meet-late-october-on-amags-makena-for-preterm-births\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA advisory committee to meet late October on AMAG&#39;s Makena for preterm births</a></h4><ul><li>The FDA will hold an advisory committee meeting on Tuesday, October 29, to review and discuss the results from a failed Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01004029?titles=prolong&amp;spons=amag&amp;rank=1\" target=\"_blank\">PROLONG</a>, evaluating AMAG Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a> <font color=\"red\">-1.9%</font>) Makena (hydroxyprogesterone caproate injection) for preventing preterm births in women with histories of prior spontaneous singleton preterm deliveries.</li><li>Shares sold off in March when the company <a href=\"https://seekingalpha.com/news/3441139-amag-pharma-6-percent-premarket-disappointing-makena-data\" target=\"_blank\">announced </a>that Makena failed to separate from placebo as measured by the rate of preterm delivery.</li><li>The FDA approved it in February 2011 to reduce the risk of preterm birth in at-risk pregnant women.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501133\" data-linked=\"FDA advisory committee to meet late October on AMAG&#39;s Makena for preterm births\" data-tweet=\"$AMAG - FDA advisory committee to meet late October on AMAG&#39;s Makena for preterm births https://seekingalpha.com/news/3501133-fda-advisory-committee-to-meet-late-october-on-amags-makena-for-preterm-births?source=tweet\" data-url=\"https://seekingalpha.com/news/3501133-fda-advisory-committee-to-meet-late-october-on-amags-makena-for-preterm-births\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501132\" data-ts=\"1569246814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501132-onconova-therapeutics-announces-3_4m-registered-direct-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova Therapeutics announces $3.4M registered direct offering</a></h4><ul> <li>Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics, Inc.'>ONTX</a>) is down <font color=\"red\">24%</font> after <a href=\"https://seekingalpha.com/pr/17640098-onconova-therapeutics-inc-announces-3_4-million-registered-direct-offering-common-stock\" target=\"_blank\">entering</a> into securities purchase agreements with certain institutional investors to purchase 2,136,193 common shares at $1.60/share in a registered direct offering for aggregate gross proceeds of ~$3.4M.</li><li>Closing date is September 25.</li><li>Also, the price and term of warrants issued in February 2018 and/or April 2018 will be amended to $1.60/share and extended to December 31, 2022.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3501132\" data-linked=\"Onconova Therapeutics announces $3.4M registered direct offering\" data-tweet=\"$ONTX - Onconova Therapeutics announces $3.4M registered direct offering https://seekingalpha.com/news/3501132-onconova-therapeutics-announces-3_4m-registered-direct-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3501132-onconova-therapeutics-announces-3_4m-registered-direct-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501126\" data-ts=\"1569246221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPTN\" target=\"_blank\">NPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501126-neophotonicsminus-2_9-facing-demand-challenges-says-needham\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeoPhotonics -2.9% facing demand challenges, says Needham</a></h4><ul><li>NeoPhotonics (NYSE:<a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a>) faces \"spotty at best\" demand prospects due to continuing trade war risks, says Needham.</li><li>The firm says Huawei's visibility \"remains murky,\" and notes that Huawei is NPTN's largest customer.</li><li>Second-largest customer Ciena has demand growth that \"appears to be cooling sharply\" and could come in at \"mid- to even low single-digit rate for the next 2-3 quarters.\"</li><li>Needham has a Hold rating on NeoPhotonics. The company has an Outperform average <a href=\"https://seekingalpha.com/symbol/NPTN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>NPTN shares are <font color=\"red\">down 2.9%</font> to $6.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501126\" data-linked=\"NeoPhotonics -2.9% facing demand challenges, says Needham\" data-tweet=\"$NPTN - NeoPhotonics -2.9% facing demand challenges, says Needham https://seekingalpha.com/news/3501126-neophotonicsminus-2_9-facing-demand-challenges-says-needham?source=tweet\" data-url=\"https://seekingalpha.com/news/3501126-neophotonicsminus-2_9-facing-demand-challenges-says-needham\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501123\" data-ts=\"1569245866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501123-weak-guidance-weighs-on-overstock-along-cfo-exit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak guidance weighs on Overstock along with CFO exit</a></h4><ul> <li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) updated <a href=\"https://seekingalpha.com/pr/17639932-overstock-appoints-jonathan-johnson-ceo-robert-hughes-acting-cfo\" target=\"_blank\">guidance</a> along with its earlier announcement on the resignation of its CFO.</li> <li>The company says Q3 EBITDA is \"break-even\" to fall below the prior outlook for \"significant positive\" EBITDA for the period. Management points to higher tariff costs, increased D&amp;O insurance costs and a lower than anticipated conversion rate on high dollar purchases across the industry.</li> <li>Overstock still expects \"modest\" positive EBITDA for Q4.</li> <li>Overstock is <font color=\"red\">down 10.29%</font> in early trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501123\" data-linked=\"Weak guidance weighs on Overstock along with CFO exit\" data-tweet=\"$OSTK - Weak guidance weighs on Overstock along with CFO exit https://seekingalpha.com/news/3501123-weak-guidance-weighs-on-overstock-along-cfo-exit?source=tweet\" data-url=\"https://seekingalpha.com/news/3501123-weak-guidance-weighs-on-overstock-along-cfo-exit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501116\" data-ts=\"1569245288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501116-steel-names-downgraded-j-p-morgan-on-weak-steel-price-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel names downgraded at J.P. Morgan on weak steel price outlook</a></h4><ul><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color=\"red\">-3.4%</font>, AK Steel (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a>) <font color=\"red\">-5.3%</font> and Cleveland-Cliffs (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a>) <font color=\"red\">-3.2%</font> pre-market after J.P. Morgan <a href=\"https://www.cnbc.com/2019/09/23/analyst-calls-of-the-day-amazon-chewy-lululemon-clorox-more.html\" target=\"_blank\">downgrades</a> shares of the three steel producers, saying \"the uncertainty around trade and supply addition announcements are  weighing on sentiment and pricing, which have lowered our steel price  expectation for the foreseeable future.\"</li><li>If current economic and trade conditions hold, we think steel prices  will likely fluctuate between $500 and 600/ton over the near to medium  term, with prices likely easing somewhat further over the next couple of  months and then rebounding modestly heading into 2020,\" JPM's Michael Gambardella says.</li><li>On U.S. Steel, Gambardella cuts shares to Neutral from Overweight with a $12 price target, trimmed from $14, citing the company's reduced outlook for an adjusted Q3 loss of $0.35/share and continued idling two of its main U.S. blast furnaces.</li><li>JPM double-downgrades AKS to Underweight from Overweight, citing valuation headwinds and its belief that the strike at General Motors may weigh on the company's earnings, and CLF to Neutral from Overweight on lower pellet premiums and steel prices.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501116\" data-linked=\"Steel names downgraded at J.P. Morgan on weak steel price outlook\" data-tweet=\"$X $AKS $CLF - Steel names downgraded at J.P. Morgan on weak steel price outlook https://seekingalpha.com/news/3501116-steel-names-downgraded-j-p-morgan-on-weak-steel-price-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3501116-steel-names-downgraded-j-p-morgan-on-weak-steel-price-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501108\" data-ts=\"1569244492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501108-piper-jaffray-sees-lululemon-running-to-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray sees Lululemon running to new high</a></h4><ul> <li>Piper Jaffray joins the bull camp on Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) by starting off coverage with an Overweight rating and price target of <a href=\"https://www.cnbc.com/2019/09/23/analyst-calls-of-the-day-amazon-chewy-lululemon-clorox-more.html\" target=\"_blank\">$227</a>.</li> <li>PJ on the athletic apparel retailer: \"We see the brand as a share gainer in a secularly growing category with accelerating opportunity in men\u2019s and international. While shares are close to their 52-week high and investors expect on-going DD growth in women\u2019s and steady mix shift to higher-margin digital, we believe men\u2019s, better-than-expected performance in China (28 stores today of 460 total), improving profitability in Europe, success in recently launched selfcare, and loyalty program adoption could be upside catalysts.\"</li>  <li>The Wall Street <a href=\"https://seekingalpha.com/symbol/LULU/ratings/sell-side-ratings\" target=\"_blank\">ratings scorecard</a> on Lululemon now shows 19 Buy-equivalent ratings vs. 13 Hold-equivalent ratings and 1 lonely Sell rating.</li> <li>LULU <font color=\"green\">+0.22%</font> premarket to $189.71.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501108\" data-linked=\"Piper Jaffray sees Lululemon running to new high\" data-tweet=\"$LULU - Piper Jaffray sees Lululemon running to new high https://seekingalpha.com/news/3501108-piper-jaffray-sees-lululemon-running-to-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3501108-piper-jaffray-sees-lululemon-running-to-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501107\" data-ts=\"1569244415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501107-mt-uxin-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MT, UXIN among premarket losers</a></h4><ul><li>Reebonz Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"red\">-32%</font> on <a href=\"https://seekingalpha.com/news/3501018-reebonz-holding-limited-reports-1h-results\" target=\"_blank\">1H earnings</a>.</li><li>Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics, Inc.'>ONTX</a>) <font color=\"red\">-21%</font> on <a href=\"https://seekingalpha.com/pr/17640098-onconova-therapeutics-inc-announces-3_4-million-registered-direct-offering-common-stock\" target=\"_blank\">announcing</a> $3.4M registered direct offering.</li><li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) <font color=\"red\">-12%</font> after <a href=\"https://seekingalpha.com/news/3501088-overstock-minus-12-percent-cfo-steps\" target=\"_blank\">CFO steps down</a>.</li><li>Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3501009-uxin-eps-beats-0_07\" target=\"_blank\">Q2 earnings</a>.</li><li>Pennsylvania Real Estate Investment Trust (NYSE:<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3501052-citi-cuts-preit-sabra-simon-upgrades-ps-business-parks\" target=\"_blank\">analyst</a> downgrade.</li><li>AK Steel Holding (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a>) <font color=\"red\">-5%</font>.</li><li>ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>) <font color=\"red\">-5%</font>.</li><li>Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501107\" data-linked=\"MT, UXIN among premarket losers\" data-tweet=\"$RBZ $ONTX $OSTK - MT, UXIN among premarket losers https://seekingalpha.com/news/3501107-mt-uxin-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501107-mt-uxin-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501101\" data-ts=\"1569244243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501101-mnk-exas-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MNK, EXAS among premarket gainers</a></h4><ul><li>Plus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a>) <font color=\"green\">+99%</font> on <a href=\"https://seekingalpha.com/news/3501026-plus-therapeutics-74-percent-premarket-barda-payment\" target=\"_blank\">BARDA payment</a>.</li><li>Avadel Pharmaceuticals plc (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <font color=\"green\">+33%</font> after <a href=\"https://seekingalpha.com/news/3501071-avadel-pharma-plus-31-percent-premarket-fda-approves-rest-trial-amendment\" target=\"_blank\">FDA approves</a> REST-ON trial amendment.</li><li>Arotech (NASDAQ:<a href='https://seekingalpha.com/symbol/ARTX' title='Arotech Corporation'>ARTX</a>) <font color=\"green\">+32%</font> on being <a href=\"https://seekingalpha.com/news/3501064-arotech-acquired-greenbriar-3-share-cash\" target=\"_blank\">acquired</a> by Greenbriar.</li><li>Mallinckrodt plc (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>) <font color=\"green\">+18%</font> on <a href=\"https://seekingalpha.com/news/3501042-mallinckrodt-25-percent-premarket-positive-stratagraft-data\" target=\"_blank\">positive StrataGraft data</a>.</li><li>Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) <font color=\"green\">+10%</font>.</li><li>PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3501081-polarityte-11-percent-premarket-positive-skinte-data\" target=\"_blank\">positive SkinTE data</a>.</li><li>Intec Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma Ltd.'>NTEC</a>) <font color=\"green\">+7%</font>.</li><li>Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color=\"green\">+6%</font>.</li><li>Endeavour Silver (NYSE:<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a>) <font color=\"green\">+6%</font>.</li><li>ZIOPHARM Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a>) <font color=\"green\">+6%</font>.</li><li>Exact Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='Exact Sciences Corporation'>EXAS</a>) <font color=\"green\">+5%</font> as <a href=\"https://seekingalpha.com/news/3501019-fda-oks-exacts-cologuard-younger-people\" target=\"_blank\">FDA OKs</a> Exact's Cologuard for younger people.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501101\" data-linked=\"MNK, EXAS among premarket gainers\" data-tweet=\"$PSTV $AVDL $ARTX - MNK, EXAS among premarket gainers https://seekingalpha.com/news/3501101-mnk-exas-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3501101-mnk-exas-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501096\" data-ts=\"1569243873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLX\" target=\"_blank\">CLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501096-barclays-warns-on-clorox\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays warns on Clorox</a></h4><ul> <li>Barclays drops Clorox (NYSE:<a href='https://seekingalpha.com/symbol/CLX' title='The Clorox Company'>CLX</a>) to an Underweight <a href=\"https://www.cnbc.com/2019/09/23/analyst-calls-of-the-day-amazon-chewy-lululemon-clorox-more.html\" target=\"_blank\">rating</a> from Equal Weight due to the risk earnings will tail off below expectations.</li> <li>\"Though the company has discussed several troubled categories in recent quarters, the latest data suggests the issues at hand are increasing both in terms of breadth (moving to other key categories such as bleach, litter, salad dressing and cleaners) and depth (affecting sales, shares, and distribution),\" warns the firm.</li> <li>\"While we have long admired Clorox\u2019s capabilities to maneuver through cost &amp; pricing cycles, we find this one is proving to paint a different picture,\" adds the analyst team.</li><li>Barclays assigns a price target of $141 to CLX vs. the <a href=\"https://seekingalpha.com/symbol/CLX/ratings/sell-side-ratings\" target=\"_blank\">sell-side consensus PT</a> of $151.76.</li> <li>The cut on Clorox stands out with Barclays turning <a href=\"https://seekingalpha.com/news/3501083-barclays-sees-kimberly-clark-trading-discount\" target=\"_blank\">bullish</a> on Kimberly-Clark earlier in the day.</li> <li>Shares of Clorox are <font color=\"red\">down 0.87%</font> premarket to $150.46.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3501096\" data-linked=\"Barclays warns on Clorox\" data-tweet=\"$CLX - Barclays warns on Clorox https://seekingalpha.com/news/3501096-barclays-warns-on-clorox?source=tweet\" data-url=\"https://seekingalpha.com/news/3501096-barclays-warns-on-clorox\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501094\" data-ts=\"1569243647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501094-abeona-not-quite-late-stage-study-of-ebminus-101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona not quite there with late-stage study of EB-101</a></h4><ul><li>Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <a href=\"https://seekingalpha.com/pr/17640093-abeona-therapeutics-provides-regulatory-update-ahead-pivotal-phase-3-clinical-trial-ebminus\" target=\"_blank\">reports </a>that the FDA has placed  a clinical hold on its planned Phase 3 clinical trial evaluating autologous cell therapy EB-101 in patients with recessive dystrophic epidermolysis bullosa until it receives and reviews additional data on EB-101's transport stability to clinical trial sites. The company intends to resolve the issue as soon as feasible and maintains its expectation of FDA sign-off on the trial in Q4.</li><li>The stock sold off in November 2018 after the company <a href=\"https://seekingalpha.com/news/3408606-abeona-17-percent-delay-late-stage-study-ebminus-101-rdeb\" target=\"_blank\">announced </a>a delay in the start of the study.</li><li>Shares, currently halted, will resume trading at 9:15 am ET.</li><li>Management will host a conference call this morning at 9:30 am ET to discuss the matter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501094\" data-linked=\"Abeona not quite there with late-stage study of EB-101\" data-tweet=\"$ABEO - Abeona not quite there with late-stage study of EB-101 https://seekingalpha.com/news/3501094-abeona-not-quite-late-stage-study-of-ebminus-101?source=tweet\" data-url=\"https://seekingalpha.com/news/3501094-abeona-not-quite-late-stage-study-of-ebminus-101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501088\" data-ts=\"1569243361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501088-overstockminus-12-after-cfo-steps-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock -12% after CFO steps down</a></h4><ul> <li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) announces the appointment of Jonathan Johnson as CEO.</li>  <li>Johnson had been serving as interim CEO since August 22.</li>  <li>Johnson says he knows how to unlock the value in each of Overstock's unique businesses. \"I\u2019m confident we can rapidly return our retail business to profitable growth Our transformative blockchain businesses continue to lead their respective industries by getting real products into production,\" he says.</li>    <li>In addition, the company says CFO Greg Iverson has resigned. The company has appointed its previous principal financial officer, Robert Hughes, as acting chief financial officer and begun a search for a permanent CFO.</li><li>OSTK  <font color=\"red\">-11.89%</font> premarket to  $13.19.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17639932-overstock-appoints-jonathan-johnson-ceo-robert-hughes-acting-cfo\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3501088\" data-linked=\"Overstock -12% after CFO steps down\" data-tweet=\"$OSTK - Overstock -12% after CFO steps down https://seekingalpha.com/news/3501088-overstockminus-12-after-cfo-steps-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3501088-overstockminus-12-after-cfo-steps-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501081\" data-ts=\"1569242650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501081-polarityte-up-11-premarket-on-positive-skinte-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolarityTE up 11% premarket on positive SkinTE data</a></h4><ul><li>Thinly traded micro cap PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) is up <font color=\"green\">11%</font> premarket on modestly higher volume in reaction to positive <a href=\"https://seekingalpha.com/pr/17639879-polarityte-announces-positive-data-showing-skinte-regenerated-full-thickness-skin-difficult\" target=\"_blank\">results</a> from a retrospective study of its SkinTE skin regeneration product in patients with difficult-to-treat wounds. The data were presented at the American Society of Plastic Surgeons scientific meeting in San Diego.</li><li>All 15 patients who received a single application of SkinTE achieved complete wound closure. Cases included four late burn reconstructions, one acute flame burn, three acute traumas, one anterolateral thigh donor site and six chronic wounds from diabetic foot and venous leg ulcers, a trauma and a spider bite. No complications were observed and no repeat treatments were required.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501081\" data-linked=\"PolarityTE up 11% premarket on positive SkinTE data\" data-tweet=\"$PTE - PolarityTE up 11% premarket on positive SkinTE data https://seekingalpha.com/news/3501081-polarityte-up-11-premarket-on-positive-skinte-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3501081-polarityte-up-11-premarket-on-positive-skinte-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501078\" data-ts=\"1569242337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OR\" target=\"_blank\">OR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501078-osisko-gold-offers-to-buy-barkerville-gold-for-c-338m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Osisko Gold offers to buy Barkerville Gold for C$338M</a></h4><ul><li>Osisko Gold Royalties (NYSE:<a href='https://seekingalpha.com/symbol/OR' title='Osisko Gold Royalties Ltd'>OR</a>) <font color=\"red\">-4.1%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17639678-osisko-gold-royalties-acquire-barkerville-gold-mines\" target=\"_blank\">agreeing to acquire</a> all issued and outstanding common shares of Barkerville Gold Mines (<a href='https://seekingalpha.com/symbol/BGMZF' title='Barkerville Gold Mines Ltd.'>OTCPK:BGMZF</a>) it does not already own in a deal valued at C$338M.</li><li>Under the deal terms, each Barkerville shareholder would receive 0.0357 common share of Osisko for each share of Barkerville held, implying a value of C$0.58/share, based on Osisko's Sept. 20 closing price on the Toronto Stock Exchange.</li><li>Osisko says Barkerville's Cariboo Gold project in British Columbia will add a potentially world-class asset to its portfolio.</li><li>Osisko also announces the creation of North Spirit Discovery Group, which aims to become a leading resource development and finance company with the assistance of joint venture partners and/or private equity capital.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501078\" data-linked=\"Osisko Gold offers to buy Barkerville Gold for C$338M\" data-tweet=\"$OR $BGMZF - Osisko Gold offers to buy Barkerville Gold for C$338M https://seekingalpha.com/news/3501078-osisko-gold-offers-to-buy-barkerville-gold-for-c-338m?source=tweet\" data-url=\"https://seekingalpha.com/news/3501078-osisko-gold-offers-to-buy-barkerville-gold-for-c-338m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501074\" data-ts=\"1569241856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTWK\" target=\"_blank\">NTWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501074-netsol-eps-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetSol EPS beats by $0.12, beats on revenue</a></h4><ul><li>NetSol (NASDAQ:<a href='https://seekingalpha.com/symbol/NTWK' title='NetSol Technologies, Inc.'>NTWK</a>): Q4 GAAP EPS of $0.30 <font color=\"green\">beats by $0.12</font>.</li><li>Revenue of $17.3M (+4.2% Y/Y) <font color=\"green\">beats by $0.9M</font>.</li><li>Shares <font color=\"green\">+6.5%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17639901-netsol-technologies-reports-fiscal-fourth-quarter-full-year-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3501074\" data-linked=\"NetSol EPS beats by $0.12, beats on revenue\" data-tweet=\"$NTWK - NetSol EPS beats by $0.12, beats on revenue https://seekingalpha.com/news/3501074-netsol-eps-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3501074-netsol-eps-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501072\" data-ts=\"1569241839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUTL\" target=\"_blank\">AUTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501072-piper-likes-edwards-lifesciences-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper likes Edwards Lifesciences in premarket analyst action</a></h4><ul><li>Autolus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AUTL' title='Autolus Therapeutics plc'>AUTL</a>) initiated with Buy rating and $26 (99% upside) price target at Needham.</li><li>Edwards Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corporation'>EW</a>) initiated with Overweight rating and $240 (9% upside) price target at Piper Jaffray.</li><li>Elanco Animal Health (NYSE:<a href='https://seekingalpha.com/symbol/ELAN' title='Elanco Animal Health Incorporated'>ELAN</a>) initiated with Overweight rating and $36 (31% upside) price target at Barclays.</li><li>Zynex (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYXI' title='Zynex, Inc.'>ZYXI</a>) initiated with Buy rating and $12 (20% upside) price target at H.C. Wainwright.</li><li>Agios Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a>) upgraded to Buy with a $55 (51% upside) price target at Guggenheim.</li><li>Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) upgraded to Buy with a $403 (36% upside) price target at Guggenheim.</li><li>Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) upgraded to Buy at with a \u20ac96 (14% upside)at Guggenheim. Shares down <font color=\"red\">1%</font> premarket.</li><li>Exact Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='Exact Sciences Corporation'>EXAS</a>) upgraded to Buy with a $130 (25% upside) price target at Benchmark. Shares up <font color=\"green\">6%</font> premarket on FDA nod for expanded use of Cologuard.</li><li>Akcea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics, Inc.'>AKCA</a>) downgraded to Market Perform with a $24 (7% upside) price target at Wells Fargo.</li><li>Avita Medical (<a href='https://seekingalpha.com/symbol/AVMXY' title='Avita Medical Limited'>OTCQX:AVMXY</a>) downgraded to Speculative Hold at Bell Potter.</li><li>Sabra Health Care REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a>) downgraded to Sell at Citigroup.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501072\" data-linked=\"Piper likes Edwards Lifesciences in premarket analyst action\" data-tweet=\"$AUTL $EW $ELAN - Piper likes Edwards Lifesciences in premarket analyst action https://seekingalpha.com/news/3501072-piper-likes-edwards-lifesciences-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3501072-piper-likes-edwards-lifesciences-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501071\" data-ts=\"1569241533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVDL\" target=\"_blank\">AVDL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501071-avadel-pharmaplus-31-premarket-after-fda-approves-rest-on-trial-amendment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avadel Pharma +31% premarket after FDA approves REST-ON trial amendment</a></h4><ul> <li>Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) is up <font color=\"green\">31%</font> premarket after FDA <a href=\"https://seekingalpha.com/pr/17639808-avadel-pharmaceuticals-announces-fda-agreement-reduce-sample-size-ongoing-pivotal-phase-3\" target=\"_blank\">agrees</a> with its proposed amendments to the statistical analysis plan <em>for the REST-ON Phase 3 study for once-nightly sodium oxybate, FT218</em>.</li><li>No modifications were made to the fundamental design of the study, including the primary or secondary endpoints, dosing scheme or duration of the study.</li>     <li>The REST-ON study will now target enrolling 205 patients.  Based on this updated target sample size and enrollment currently at 193 patients, the company now expects to complete enrollment by the end of 2019 and have topline data in Q2 2020.</li><li>This is up to a year ahead of expectations to complete enrollment for the previous target of 264 patients for the study.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3501071\" data-linked=\"Avadel Pharma +31% premarket after FDA approves REST-ON trial amendment\" data-tweet=\"$AVDL - Avadel Pharma +31% premarket after FDA approves REST-ON trial amendment https://seekingalpha.com/news/3501071-avadel-pharmaplus-31-premarket-after-fda-approves-rest-on-trial-amendment?source=tweet\" data-url=\"https://seekingalpha.com/news/3501071-avadel-pharmaplus-31-premarket-after-fda-approves-rest-on-trial-amendment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501060\" data-ts=\"1569240353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TELL\" target=\"_blank\">TELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501060-tellurian-inks-investment-deal-indian-firm-for-driftwood-lng-terminal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tellurian inks investment deal with Indian firm for Driftwood LNG terminal</a></h4><ul><li>Tellurian (NASDAQ:<a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a>) <font color=\"green\">+9.4%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17639476-tellurian-petronet-sign-mou-5-million-tonnes-lng-equity-investment-driftwood\" target=\"_blank\">signing a memorandum of understanding</a> with India's Petronet LNG for the purchase of as much as 5M metric tons/year of liquefied natural gas from its planned Driftwood LNG export terminal, confirming an <a href=\"https://seekingalpha.com/news/3500807-petronet-sign-2_5b-lng-deal-tellurian-reuters\" target=\"_blank\">earlier report.</a></li><li>Petronet will spend $2.5B for an 18% equity stake in the $28B terminal, the largest outside holding so far in the project and <a href=\"https://finance.yahoo.com/news/tellurian-signs-7-5-billion-232546928.html\" target=\"_blank\">one of the largest foreign investments</a> in the U.S. to ship shale gas abroad.</li><li>The Driftwood project includes natural gas production, gathering, processing and transportation facilities, along with Driftwood LNG, a proposed ~27.6M mt/year liquefaction export facility to be located near Lake Charles, La.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501060\" data-linked=\"Tellurian inks investment deal with Indian firm for Driftwood LNG terminal\" data-tweet=\"$TELL - Tellurian inks investment deal with Indian firm for Driftwood LNG terminal https://seekingalpha.com/news/3501060-tellurian-inks-investment-deal-indian-firm-for-driftwood-lng-terminal?source=tweet\" data-url=\"https://seekingalpha.com/news/3501060-tellurian-inks-investment-deal-indian-firm-for-driftwood-lng-terminal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501052\" data-ts=\"1569239622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEI\" target=\"_blank\">PEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501052-citi-cuts-preit-sabra-and-simon-upgrades-ps-business-parks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi cuts PREIT, Sabra, and Simon; upgrades PS Business Parks</a></h4><ul><li>Pennsylvania REIT (NYSE:<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a>) <font color=\"red\">slumps 2.9%</font> in premarket trading after Citi downgrades the REIT to sell from neutral.</li><li>Citi also cuts Sabra Healthcare REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a>) to sell from neutral and Simon Property (NYSE:<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a>) to neutral from buy.</li><li>PS Business Parks (NYSE:<a href='https://seekingalpha.com/symbol/PSB' title='PS Business Parks, Inc.'>PSB</a>) to neutral from sell.</li><li>Sabra <font color=\"red\">falls 0.6%</font> and Simon is <font color=\"red\">down 0.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501052\" data-linked=\"Citi cuts PREIT, Sabra, and Simon; upgrades PS Business Parks\" data-tweet=\"$PEI $SBRA $SPG - Citi cuts PREIT, Sabra, and Simon; upgrades PS Business Parks https://seekingalpha.com/news/3501052-citi-cuts-preit-sabra-and-simon-upgrades-ps-business-parks?source=tweet\" data-url=\"https://seekingalpha.com/news/3501052-citi-cuts-preit-sabra-and-simon-upgrades-ps-business-parks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501050\" data-ts=\"1569239219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501050-needham-turns-bullish-on-juniper-jnprplus-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham turns bullish on Juniper; JNPR +3.5%</a></h4><ul><li>Needham upgrades Juniper Networks (NYSE:<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks, Inc.'>JNPR</a>) from Hold to Buy with a $29 price target, a 22% upside.</li><li>Analyst Alex Henderson says Juniper \"will stabilize its results in CY3Q and post a return to yr-yr growth in CY4Q.\"</li><li>Henderson thinks Juniper could benefit from easier comps ahead and from the rebound in cloud spending.</li><li>Juniper will <a href=\"https://seekingalpha.com/symbol/JNPR/earnings\" target=\"_blank\">report earnings</a> October 24. Consensus estimates expect $1.15B in revenue with $0.46 EPS.</li><li>Juniper shares are <font color=\"green\">up 3.5%</font> pre-market to $24.60. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/JNPR/ratings/author-ratings#filter=all\" target=\"_blank\">SA Authors rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501050\" data-linked=\"Needham turns bullish on Juniper; JNPR +3.5%\" data-tweet=\"$JNPR - Needham turns bullish on Juniper; JNPR +3.5% https://seekingalpha.com/news/3501050-needham-turns-bullish-on-juniper-jnprplus-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3501050-needham-turns-bullish-on-juniper-jnprplus-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501048\" data-ts=\"1569238854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501048-gw-pharmas-epidyolex-okd-in-europe-shares-ahead-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma&#39;s Epidyolex OK&#39;d in Europe; shares ahead 1% premarket</a></h4><ul><li>GW Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>) is up <font color=\"green\">1%</font> premarket on light volume in reaction to Europe Commission <a href=\"https://seekingalpha.com/pr/17639764-gw-pharmaceuticals-receives-european-commission-approval-epidyolex-cannabidiol-treatment\" target=\"_blank\">approval</a> of Epidyolex (cannabidiol) for the adjunctive treatment of two rare forms of severe childhood-onset epilepsy called Lennox-Gastaut syndrome and Dravet syndrome.</li><li>The product was approved in the U.S. in June 2018 under the brand name Epidiolex.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501048\" data-linked=\"GW Pharma&#39;s Epidyolex OK&#39;d in Europe; shares ahead 1% premarket\" data-tweet=\"$GWPH - GW Pharma&#39;s Epidyolex OK&#39;d in Europe; shares ahead 1% premarket https://seekingalpha.com/news/3501048-gw-pharmas-epidyolex-okd-in-europe-shares-ahead-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3501048-gw-pharmas-epidyolex-okd-in-europe-shares-ahead-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501047\" data-ts=\"1569238708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501047-citi-names-top-semi-equipment-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi names top semi equipment stocks</a></h4><ul><li>Citi is taking a \"more offensive stance\" in semi equipment stocks, citing recent supply chain checks showing NAND prices could rise as much as 20% in Q4.</li><li>Normalizing hyperscale cloud inventory will stabilize DRAM pricing, says Citi.</li><li>The firm upgrades Advanced Energy Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/AEIS' title='Advanced Energy Industries, Inc.'>AEIS</a>) <font color=\"green\">+1.2%</font> to Buy, moves MKS Instruments (NASDAQ:<a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a>) to its top small and mid-cap pick list, and maintains Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) and Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) <font color=\"green\">+0.2%</font> as top semi equipment picks.</li><li>Brooks Automation (NASDAQ:<a href='https://seekingalpha.com/symbol/BRKS' title='Brooks Automation, Inc.'>BRKS</a>) is downgraded to Neutral and a $42 target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501047\" data-linked=\"Citi names top semi equipment stocks\" data-tweet=\"$AEIS $MKSI $LRCX - Citi names top semi equipment stocks https://seekingalpha.com/news/3501047-citi-names-top-semi-equipment-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3501047-citi-names-top-semi-equipment-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501042\" data-ts=\"1569238427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501042-mallinckrodt-up-25-premarket-on-positive-stratagraft-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mallinckrodt up 25% premarket on positive StrataGraft data</a></h4><ul><li>A Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03005106?intr=stratagraft&amp;lead=mallinckrodt&amp;phase=2&amp;rank=1\" target=\"_blank\">STRATA2016</a>, evaluating Mallinckrodt's (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>) StrataGraft regenerative tissue for the treatment of deep partial-thickness thermal burns <a href=\"https://seekingalpha.com/pr/17639689-mallinckrodt-announces-positive-top-line-results-pivotal-phase-3-clinical-trial-stratagraft\" target=\"_blank\">met both primary endpoints</a> according to the company.</li><li>Results showed that a statistically significantly smaller area of StrataGraft-treated burn wounds required autografting by month 3 compared to burn wounds treated exclusively with autograft (p&lt;0.0001). Specifically, 4% of StrataGraft-treated sites required autografting by three months compared to 100% for autograft (control) plus an additional 2% at month 3.</li><li>The proportion of StrataGraft-treated wounds that achieved closure at month 3 was 83% compared to 86% for autograft, although the company says the separation met the predefined threshold for statistical significance (unclear how).</li><li>The company plans to file a U.S. marketing application in H1 2020.</li><li>Shares up <font color=\"green\">25%</font> premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501042\" data-linked=\"Mallinckrodt up 25% premarket on positive StrataGraft data\" data-tweet=\"$MNK - Mallinckrodt up 25% premarket on positive StrataGraft data https://seekingalpha.com/news/3501042-mallinckrodt-up-25-premarket-on-positive-stratagraft-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3501042-mallinckrodt-up-25-premarket-on-positive-stratagraft-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501044\" data-ts=\"1569238422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501044-pg-and-e-formalizes-deal-to-resolve-wildfire-claims\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E formalizes deal to resolve wildfire claims</a></h4><ul><li>PG&amp;E (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) says it <a href=\"https://seekingalpha.com/pr/17639635-pg-and-e-executes-definitive-agreement-resolving-insurance-subrogation-claims-relating-2017\" target=\"_blank\">reached an agreement</a> to resolve all insurance subrogation claims from the 2017 Northern California wildfires and the 2018 Camp Fire with entities representing 85% of the claims.</li><li>PG&amp;E says the deal, subject to approval of the bankruptcy court overseeing the case, formalizes the <a href=\"https://seekingalpha.com/news/3499196-pg-and-e-reaches-11b-settlement-california-wildfire-claims\" target=\"_blank\">recently announced</a> $11B agreement in principle.</li><li>The utility says it will file an amended reorganization plan with the court to reflect  the finalized settlement and  the updated backstop financing commitments.</li><li>PG&amp;E says Elliott Management's alternative proposal is a \"blatant attempt to unjustly enrich the noteholders who proposed it\" and would \"cost all PG&amp;E customers billions of dollars in additional interest payments over 15 years, while providing an unfair windfall for the noteholders and plaintiffs' attorneys.\"</li><li>PCG <font color=\"red\">-2.6%</font> pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501044\" data-linked=\"PG&amp;E formalizes deal to resolve wildfire claims\" data-tweet=\"$PCG - PG&amp;E formalizes deal to resolve wildfire claims https://seekingalpha.com/news/3501044-pg-and-e-formalizes-deal-to-resolve-wildfire-claims?source=tweet\" data-url=\"https://seekingalpha.com/news/3501044-pg-and-e-formalizes-deal-to-resolve-wildfire-claims\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501034\" data-ts=\"1569237100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501034-tata-motors-to-accelerate-on-ev-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors to accelerate on EV production</a></h4><ul><li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) says it plans to launch a new electric vehicle in 2020.</li><li>Tata CEO Guenter Butschek says the support of the Indian government and a recent cut in taxes on electric vehicles is making it easier to move ahead with EV production.</li><li>Butschek thinks mainstream EV production is now possible.</li><li>Shares of Tata Motors are <font color=\"red\">down 3.88%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501034\" data-linked=\"Tata Motors to accelerate on EV production\" data-tweet=\"$TTM - Tata Motors to accelerate on EV production https://seekingalpha.com/news/3501034-tata-motors-to-accelerate-on-ev-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3501034-tata-motors-to-accelerate-on-ev-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501032\" data-ts=\"1569236858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKDA\" target=\"_blank\">RKDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501032-arcadia-bio-up-11-premarket-on-patent-for-reduced-gluten-grains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcadia Bio up 11% premarket on patent for reduced-gluten grains</a></h4><ul><li>Nano cap Arcadia Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences, Inc.'>RKDA</a>) is up <font color=\"green\">11%</font> premarket on light volume in reaction to is receipt of a new <a href=\"https://seekingalpha.com/pr/17639594-arcadia-biosciences-granted-u-s-patent-reduced-gluten-goodwheat\" target=\"_blank\">U.S. patent</a> covering reduced-gluten grains, its 17th in its GoodWheat portfolio of non-genetically modified wheat varieties.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501032\" data-linked=\"Arcadia Bio up 11% premarket on patent for reduced-gluten grains\" data-tweet=\"$RKDA - Arcadia Bio up 11% premarket on patent for reduced-gluten grains https://seekingalpha.com/news/3501032-arcadia-bio-up-11-premarket-on-patent-for-reduced-gluten-grains?source=tweet\" data-url=\"https://seekingalpha.com/news/3501032-arcadia-bio-up-11-premarket-on-patent-for-reduced-gluten-grains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501026\" data-ts=\"1569236555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTV\" target=\"_blank\">PSTV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501026-plus-therapeutics-up-74-premarket-on-barda-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plus Therapeutics up 74% premarket on BARDA payment</a></h4><ul><li>Nano cap Plus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a>) is up <font color=\"green\">74%</font> premarket on modest volume in reaction to its <a href=\"https://seekingalpha.com/pr/17639672-plus-therapeutics-receive-4_6mm-reimbursement-payment\" target=\"_blank\">announcement </a>that BARDA will reimburse it $4.6M for work performed during fiscal years 2012 - 2019 to account for retrospective changes in indirect cost rates under their contract. The company expects to receive the money in October.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501026\" data-linked=\"Plus Therapeutics up 74% premarket on BARDA payment\" data-tweet=\"$PSTV - Plus Therapeutics up 74% premarket on BARDA payment https://seekingalpha.com/news/3501026-plus-therapeutics-up-74-premarket-on-barda-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/3501026-plus-therapeutics-up-74-premarket-on-barda-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501019\" data-ts=\"1569235312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501019-fda-oks-exacts-cologuard-for-younger-people\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Exact&#39;s Cologuard for younger people</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17639632-cologuard-gains-fda-approval-use-younger-americans-ages-45-49\" target=\"_blank\">approves </a>the use of Exact Sciences' (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='Exact Sciences Corporation'>EXAS</a>) colorectal cancer screening test Cologuard for eligible-risk individuals as young as 45 years old, five years younger than the previous limit of 50 years old.</li><li>The company says the expanded label represents an additional potential market of ~19M Americans.</li><li>Shares up <font color=\"green\">2%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501019\" data-linked=\"FDA OKs Exact&#39;s Cologuard for younger people\" data-tweet=\"$EXAS - FDA OKs Exact&#39;s Cologuard for younger people https://seekingalpha.com/news/3501019-fda-oks-exacts-cologuard-for-younger-people?source=tweet\" data-url=\"https://seekingalpha.com/news/3501019-fda-oks-exacts-cologuard-for-younger-people\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3501007\" data-ts=\"1569231190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3501007-stocks-begin-week-on-back-foot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks begin week on the back foot</a></h4><ul><li>More clarity on Sino-U.S. trade talks is needed...</li><li>The Shanghai Composite started the week <font color=\"red\">1.1% lower</font>, while U.S. stock index futures edged <font color=\"red\">down 0.2%</font>, as Chinese trade officials cut short their trip to the U.S. on Friday, but described the discussions as \"constructive.\"</li><li>Things are more gloomy in Europe, with Germany's DAX <font color=\"red\">off 1.4%</font>, as manufacturing activity data <a href=\"https://seekingalpha.com/news/3501006-germany-teeters-toward-recession\" target=\"_blank\">deepened</a> investors' fears about a coming recession, while Britain's Thomas Cook <a href=\"https://seekingalpha.com/news/3501005-worlds-oldest-travel-firm-goes-bust\" target=\"_blank\">collapsed</a>.</li><li>Mideast tensions also saw WTI crude futures <font color=\"green\">rise nearly 1% </font>overnight to $58.66/bbl after the Pentagon deployed additional troops to the Gulf to strengthen Saudi air and missile defenses.</li></ul><div class=\"tiny-share-widget\" data-id=\"3501007\" data-linked=\"Stocks begin week on the back foot\" data-tweet=\"Stocks begin week on the back foot https://seekingalpha.com/news/3501007-stocks-begin-week-on-back-foot?source=tweet\" data-url=\"https://seekingalpha.com/news/3501007-stocks-begin-week-on-back-foot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":72,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}